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Abstract
The most commonly used interview for posttraumatic stress disorder (PTSD) is
the Clinician-Administered PTSD Scale (CAPS), a semi-structured interview patterned
after the DSM-IV criteria (Blake et al., 1990). The Computerized PTSD Scale –
Multimedia Version (CPS-M: Richard, Mayo, Bohn, Haynes, & Kolman, 1997) is a
computerized interview that is modeled after the CAPS. This study examined how well
the CPS-M agreed with the CAPS diagnostically in a clinical sample. Ninety veterans
completed the test protocol consisting of paper-and-pencil measures, the CPS-M, and the
CAPS interview. Correlations between the CAPS and CPS-M were high at the item,
subscale, and full-scale levels. Confidence interval analysis revealed that the CPS-M
scales were not significantly different from their CAPS counterparts but failed to
establish equivalence. Alpha scores for the scales indicated good internal consistency on
both the CAPS and CPS-M. Difference scores between the two instruments were
normally distributed, and scale effect sizes were negligible. ROC curve analysis for the
CPS-M revealed high diagnostic accuracy. These results present a strong case for more
widespread use of the CPS-M in the assessment of PTSD.
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Diagnostic Efficiency of the Computerized PTSD Scale – Multimedia Version (CPS-M)
in Assessing Posttraumatic Stress Disorder
Psychological assessment instruments provide clinicians with information about
the topography and/or function of behavior. Within a medical model, psychological
assessment instruments also serve to augment diagnostic decision-making. Thus, it is
critical to understand how accurately a new instrument classifies both positive and
negative diagnostic cases. In order to understand how accurate an instrument is with
regard to diagnostic classification, a criterion against which to evaluate the performance
of the new instrument is required, an incontrovertible index or so-called ―gold standard.‖
The criterion can include results from another test, a behavioral criterion, or self-report
results. The present study used the Clinician Administered PTSD Scale (CAPS), the
parent instrument of the Computerized PTSD Scale – Multimedia version (CPS – M), as
the criterion instrument. We examined the criterion-related validity of the CPS – M
using signal detection theory. Signal detection theory calculates the percentage
agreement between a new assessment instrument and a criterion with regard to the
presence or absence of a particular diagnosis. We also determined equivalence of the two
instruments using confidence interval analysis.
In the literature review that follows, psychometric properties, as well as
limitations and advantages of the CAPS, will be discussed. The review will illustrate
how the CPS-M avoids some of the shortcomings of the CAPS. Confidence interval
analysis will be described, and signal detection theory will be introduced. Prior signal
detection work involving the CAPS and other PTSD measures will be highlighted. In

addition, signal detection with non-PTSD psychological instruments and signal detection
outside the field of psychology will be discussed.
The Clinician Administered PTSD Scale
The Clinician Administered PTSD Scale is a structured interview developed by
the National Center for PTSD to diagnose posttraumatic stress symptoms (CAPS; Blake
et al., 1990). The CAPS consists of three subscales, which correspond with Criteria B, C,
and D for PTSD based on the DSM-IV-TR. Subscale B assesses reexperiencing, and this
subscale is composed of five items. Subscale C measures avoidance and numbing
symptoms in seven items, and Subscale D is composed of five items that assess
hyperarousal. The CAPS provides a structured assessment of the frequency and intensity
of each of the 17 PTSD symptoms. By combining the frequency and intensity scores for
each reported symptom, a severity score is generated for that symptom. The sum of the
17 symptom severity scores is called the Total Severity Score. Weathers, Keane, and
Davidson (2001) reported that the CAPS has been used in more than 200 studies and is
the most commonly used interview for posttraumatic stress symptoms.
Several scoring rules are used to arrive at a diagnosis of PTSD on the CAPS
(Weathers, Ruscio, & Keane, 1999). The 1-2 symptom presence rule classifies a
symptom as being present when a rating of one or higher is provided for frequency and a
two or higher is provided for intensity. The 2-2 symptom presence rule classifies a
symptom as being present when ratings of two or higher are provided for both the
frequency and intensity dimensions. The Sum 4 symptom presence rule classifies a
symptom as being present when the sum of the frequency and intensity dimensions for a
symptom is four or higher. The Total 65 rule provides a PTSD diagnosis if the sum of
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the symptom severity scores is 65 or higher. Individuals are classified as PTSD-positive
or PTSD-negative based on the dichotomous decision provided by these scoring rules.
The CAPS also yields continuous scores for frequency and intensity of symptoms, but
those values are not the focus of this paper.
Psychometric properties of the CAPS. Blake et al. (1990) performed a pilot
study after the initial development of the CAPS that compared it to the Combat Exposure
Scale (CES; Keane et al., 1989), the Mississippi Scale for Combat-Related PTSD
(Mississippi Scale; Keane, Cadell, & Taylor, 1988), and the Keane PTSD Scale of the
MMPI (PK Scale; Keane et al., 1984) in a group of 25 male combat veterans. Two
researchers independently rated seven interviews, and correlations ranged from .92 to .99
across scales (Blake et al., 1990). Blake et al. also found internal consistency alphas
between .73 and .85 for the three subscales. The CAPS correlated .70 with the
Mississippi Scale, .84 with the PK Scale, and .42 with the Combat Exposure Scale (Blake
et al., 1990).
In another study of the psychometric properties of the CAPS, Weathers, Keane,
King, and King (2001) administered the instrument twice to participants, two to three
days apart. Test-retest reliability correlations ranged from .90 to .98 across three separate
rater pairs (Weathers et al., 2001). Internal consistency alphas ranged from .85 to .87 for
the three subscales, with an alpha of .94 for the full scale (Weathers et al., 2001).
Palmieri, Weathers, Difede, and King (2007) examined the factor structure of the
CAPS and PTSD Checklist in a sample of 2,960 utility workers exposed to the World
Trade Center Ground Zero site. The relative fit of five previously supported
measurement models were tested. The first was a single-factor model reflecting PTSD as
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a single unitary construct. The second was a two-factor model composed of
reexperiencing/avoidance and numbing/hyperarousal, based on the models in studies by
Taylor, Kuch, Koch, Crockett, and Passey (1998), Buckley, Blanchard, and Hickling
(1998), Simms, Watson, and Doebbeling (2002), and Asmundson, Wright, McCreary,
and Pedlan (2003). The third was a three-factor model that parallels the DSM-IV
diagnostic criteria. The fourth was a four-factor model composed of reexperiencing,
avoidance, numbing, and hyperarousal (King et al., 1998). The fifth was a four-factor
model composed of reexperiencing, avoidance, dysphoria, and hyperarousal, supported in
Simms et al. (2002) and Baschnagel, O’Connor, Colder, and Hawk (2005). For each of
the models tested, items were specified to load on a single construct, and error terms were
uncorrelated. Palmieri et al. (2007) found that a four-factor model with distinct
reexperiencing, avoidance, numbing, and hyperarousal factors best fit the data. These
findings parallel those obtained by King et al.
Charney and Keane (2007) examined the factor structure and psychometric
properties of a Bosnian translation of the CAPS with 115 help-seeking Bosnian refugees
resettled in the Boston area. They found evidence for a two-factor model, with the first
composed of symptoms of intrusion and avoidance and the second composed of
hyperarousal and numbing (Charney & Keane, 2007). Charney and Keane calculated
partial correlations to determine effect sizes for items and to determine which factors
were most important in predicting the items. They first obtained the critical ratio (t
statistic), indicating which items have significant loadings on each factor, and then they
used this critical ratio to calculate the partial correlation for each loading. Intrusion and
avoidance partial correlations based on the two-factor model ranged from .33 (D2:
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irritability) to .82 (B4: psychological distress). Partial correlations for hyperarousal and
numbing ranged from .24 (C5: detachment) to .59 (C7: foreshortened future; Charney &
Keane, 2007).
Coefficient alpha in the Charney and Keane (2007) study was .92 for the CAPS,
and the average item-total correlation was .66 (p < .01). Coefficient alphas for the twofactor model were .88 for intrusion/avoidance and .85 for hyperarousal/numbing
(Charney & Keane, 2007). Charney and Keane reported correlations with other measures
as follows: Beck Depression Inventory (BDI): .65, p < .01; Structured Clinical Interview
for the DSM-IV (SCID): .50, p < .01; General Health Questionnaire (GHQ): .60, p < .01;
Semistructured Interview for Survivors of War (SISOW): .20, p < .05.
Renner, Salem, and Ottomeyer (2006) administered the CAPS and several others
measures to 150 asylum seekers from Chechnya, Afghanistan, and West Africa. Other
measures used by Renner et al. (2006) included the Hopkins Symptom Checklist-25
(HSCL-25; Mollica et al., 1987), the Harvard Trauma Questionnaire (HTQ; Mollica et
al., 1992), the Impact of Event Scale - Revised (IES-R; Weiss & Marmar, 1997), the
Bradford Somatic Inventory (BSI; Mumford et al., 1991), and the Social Adaptation SelfEvaluation Scale (SASS; Bosc, Dubini, & Polin, 1997). Cronbach’s alpha for the full
scale was .90 for participants from Chechnya, .91 for those from Afghanistan, and .91 for
those from West Africa (Renner et al., 2006). According to Renner et al., logistic
regression revealed that the CAPS was superior in its ability to predict traumatization,
relative to the other measures, in all three ethnic groups.
Hinton et al. (2006) administered the CAPS and the SCID to a sample of 179
Cambodian refugees exposed to genocide. Internal consistency alphas for the CAPS
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ranged from .86 to .91 across the subscales, with a coefficient alpha of .92 for the full
scale (Hinton et al., 2006). Hinton et al. reported corrected item-total correlations
ranging from .48 to .85, and the CAPS demonstrated good interrater (intraclass
correlation coefficient [ICC] = .92) and test-retest reliability (ICC = .84).
Summary of CAPS psychometric studies. Overall, the research suggests that the
CAPS is a highly reliable diagnostic instrument. Internal consistency of the CAPS
ranged from .90 to .94 for the full scale (Renner et al., 2006; Weathers et al., 2001) and
from .73 to .91 (Blake et al., 1990; Hinton et al., 2006) for the subscales. Test-retest
reliability was reported by Hinton et al. (2006) at one week as .84 and by Weathers et al.
(2001) at two to three days as ranging from .90 to .98 across three separate rater pairs.
Although the CAPS was developed to represent the three-factor structure of
PTSD as outlined in the diagnostic criteria, the extant empirical data suggest that the
underlying factor structure is somewhat different. When performing confirmatory factor
analysis, Palmieri et al. (2007) found evidence for a four-factor model composed of
reexperiencing, avoidance, numbing, and hyperarousal, which paralleled results obtained
by King et al. (1998). Using a Bosnian translation of the CAPS, Charney and Keane
(2007) found evidence for a two-factor model composed of intrusion/avoidance and
hyperarousal/numbing. Although this is not a comprehensive review of the literature on
the factor structure of the CAPS, it illustrates the common finding that it is not best
conceptualized as a three factor scale.
Studies examining the convergent and discriminant validity of the CAPS are
largely supportive of the instrument. Several studies reported correlations with other
PTSD measures, including the Combat Exposure Scale, the Mississippi Scale for
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Combat-Related PTSD, the Keane PTSD Scale of the MMPI, the Semistructured
Interview for Survivors of War, the Harvard Trauma Questionnaire, and the Impact of
Events Scale. These correlations ranged from .20 with the Semistructured Interview for
Survivors of War to .84 with the Mississippi Scale for Combat-Related PTSD.
Correlations were also reported with other psychological measures of constructs similar
to PTSD, but not isomorphic, including the Beck Depression Inventory, the Structured
Clinical Interview for the DSM-IV, the General Health Questionnaire, the Hopkins
Symptom Checklist-25, the Bradford Somatic Inventory, and the Social Adaptation SelfEvaluation Scale. Correlations between the CAPS and these measures ranged from .50
with the Structured Clinical Interview for the DSM-IV to .65 with the Beck Depression
Inventory. As expected, in general the CAPS was better correlated with measures of
PTSD than with measures of other psychological constructs or disorders.
Limitations of the CAPS. Weathers et al. (2001) listed three main criticisms of
the CAPS. The authors point out that the CAPS is cumbersome because of its length. It
takes almost an hour to administer and must be administered by a trained clinician.
Although many CAPS questions are optional probes, individuals showing symptoms
require the administration of these optional questions (Weathers et al., 2001). Second,
critics of the CAPS assert that it takes too long to learn. A final criticism includes the
overlap of the frequency and intensity prompts, which examiners have complained are
redundant (Weathers et al., 2001). Additionally, although many individuals avoid
disclosing sensitive information until they feel comfortable with a clinician, the CAPS
requires individuals to report highly sensitive information to an examiner upon the first
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meeting. Of course, this last shortcoming is not a limitation of the CAPS alone but is a
characteristic of all interview-based assessments.
Computerized PTSD Scale – Multimedia Version
An alternative to the CAPS is a computerized adaptation that would address
several of these limitations. Previous attempts have been made to computerize the CAPS.
Neal, Busuttil, Herepath, and Strike (1994) administered a computerized version and the
original CAPS to a group of 40 military members with varying trauma histories. They
found that 95% of the cases were diagnosed accurately and reported a kappa of .90
between the computerized version and the CAPS with regard to PTSD presence (Neal et
al., 1994). Alpha coefficients for the intensity scores were over .90 for both the
computerized version and the CAPS, and the correlation for intensity ratings between the
two versions was .95 (Neal et al., 1994).
More recently, the Computerized PTSD Scale-Multimedia Version, or CPS-M,
was developed by Richard et al. (1997). Because it is computerized, the CPS-M requires
no training to administer. It also requires no clinician time to administer, providing an
additional time savings. In addition, participants can complete the administration in half
the time required to administer the CAPS. Mainka (2005) administered the CAPS and
CPS-M to a sample of 40 students with a trauma history and reported item-level
correlations between the instruments ranging from .42 to .89 and scale-level correlations
of .86, .89, and .84 for subscales B, C, and D, respectively. The Total Severity Score
correlation between the two measures was .92, indicating strong associations between the
instruments (Mainka, 2005). Using the CAPS as the criterion, Mainka found sensitivity
of .63, specificity of .80, and overall diagnostic efficiency of .78 using a cut score of 45.
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Aside from these two adaptations, no other attempts to computerize the CAPS are
published in the literature. Furthermore, Neal et al. (1994) have not reported any further
validation attempts for their instrument. This study aims to validate the CPS-M in a
clinical sample using confidence interval analysis to determine equivalence and signal
detection theory to determine diagnostic accuracy, relative to the CAPS.
Confidence Interval Analysis
Confidence interval analysis is a statistical procedure used to establish
equivalency of two methods or instruments. Rogers, Howard, and Vessey (1993) argued
that two instruments are equivalent if the confidence interval of the test instrument is
contained entirely within a prespecified equivalence interval of the criterion. The
equivalence interval has customarily been defined as ± 10% of the criterion mean and
reflects the legacy of the confidence interval approach in evaluating the equivalence of
newly developed pharmaceuticals (Rogers et al., 1993). To conduct the analysis, Rogers
et al. recommend using the 90% confidence interval to determine the equivalency of the
instrument while the 95% confidence interval is used to assess whether the test and
criterion means are significantly different. If the 90% confidence interval for the CPS-M
is entirely encompassed by the CAPS equivalence range (Mean of CAPS ± 10%), one
would conclude that the two instruments are equivalent. If the 95% confidence interval
of the test instrument includes zero (i.e., the difference between the means is zero), one
may conclude that the two instruments are not statistically different.
Confidence intervals are determined using the following formula: (M1-M2) ±
(zα)(SM1-M2). In this equation, M1 represents the criterion mean and M2 represents the test
instrument mean. To establish a 90% confidence interval, zα = 1.645, and zα = 1.96 when
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determining a 95% confidence interval. This value is multiplied by the standard error of
the difference between means (SM1-M2) and then added to or subtracted from the
difference between means to produce the upper and lower confidence limits, respectively.
The upper and lower limits of the confidence interval are then divided by the criterion
mean, turning them into percentages of the criterion mean. This standardizes the values
and allows for direct comparison with the ±10% equivalence interval.
Four classifications are possible using confidence interval analysis. ―Statistically
Different and Not Equivalent‖ applies when the 90% confidence interval is not contained
entirely within the equivalence interval and the 95% confidence interval excludes zero.
Two examples of this case are provided in the first panel of Figure 1. Figure 1 expresses
the equivalence and confidence intervals as percentages of the criterion mean, which
standardizes the values. ―Not Different and Statistically Equivalent‖ applies when the
90% confidence interval falls within the equivalence interval and the 95% confidence
interval includes zero. See the second panel of Figure 1. ―Statistically Different and
Statistically Equivalent‖ refers to cases in which the 90% confidence interval falls within
the equivalence interval, but the 95% confidence interval excludes zero. See the third
panel of Figure 1. Finally, ―Not Different and Not Equivalent‖ refers to cases in which
the 90% confidence interval is not contained entirely within the equivalence interval and
the 95% confidence interval includes zero. See the fourth panel of Figure 1.
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Figure 1. Rogers et al. (1993) confidence interval classifications.
Signal Detection Theory
When validating a new assessment instrument, it is necessary to determine its
ability to accurately predict or its association with scores on a relevant outcome variable,
also known as criterion related validity (Weathers, Keane, King, and King, 2001). Signal
detection theory has been used in psychological and medical studies to compare new
instruments, treatments, or diagnostic tools with already established ―gold standards‖
within the field. Briefly, signal detection techniques provide a way to evaluate the effect
of varying a cutoff score on a diagnostic test while holding constant a criterion against
which the test is measured. As a result, a variety of indices regarding diagnostic
efficiency may be calculated as a function of selected test cutoff points.
Signal detection theory was originally used in electrical engineering to determine
the presence of a signal in background noise (DeCarlo, 1998; Siegel, Vukicevic, Elliott,
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& Kraemer, 1989; Youngstrom, Findling, Danielson, & Calabrese, 2001). The same
methods can also describe and predict the performance of a receiver, such as a diagnostic
interview, in detecting the presence of a psychological stimulus of psychiatric diagnosis
(Greig, 1990). Tanner and Swets (1954) were among the first to apply signal detection
theory to the field of psychology when they examined the threshold at which humans
were capable of detecting and recognizing sensory input. The technique was later
expanded to allow researchers to determine the cut-point at which instruments made
optimally accurate classifications (Swets, 1998).
Several signal detection terms are commonly employed. Sensitivity is the
probability of a positive test, given a positive diagnosis on the criterion measure.
Specificity is the probability of a negative test given a negative diagnosis on the criterion
measure. The probability of a diagnosis on the criterion measure, given a positive test
result, is called positive predictive power. The probability of non-diagnosis on the
criterion measure, given a negative test result, is called negative predictive power.
Overall diagnostic efficiency, or diagnostic utility, is the rate of agreement
between the test and criterion measure across all cases. In the present study, the term
actual diagnosis refers to the diagnosis provided via ratings on the CAPS criterion. True
positives or true negatives occur when the positive or negative diagnosis provided by the
CPS – M agrees with the criterion. When a test assessment instrument gives a diagnosis
that does not correspond with the actual diagnosis, the result is a false positive or false
negative. False positives occur when the test instrument provides a positive diagnosis
when the disorder is not present, and a false negative occurs when the test instrument
fails to provide a positive diagnosis when the disorder is present. The cases where the
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new instrument agrees with the actual diagnosis (true positives or true negatives) are hits,
while cases where the new instrument does not agree with the actual diagnosis (false
positives and false negatives) are termed misses.
Figure 2 shows the 2 X 2 contingency table that results from diagnostic efficiency
calculations. According to Swets (1988), the decision criterion is the amount of
favorable evidence necessary to issue a positive diagnosis. This decision criterion is
determined by plotting the false positive proportion against the true positive proportion
(Swets, 1988). Since there are as many potential diagnostic cutoff points on the test as
there are discrete points on its scale of measurement, an underlying distribution of
diagnostic efficiency can be created. This underlying probability distribution is
represented by the receiver operating characteristic, or the ROC curve (DeCarlo, 1998;
Swets, 1988).

Sensitivity =

a
a+b

Specificity =

d
c+d

Figure 2. Two-by-two contingency table used for calculation of diagnostic efficiency
statistics.
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The ROC curve is obtained by plotting sensitivity, P(S/s) against false alarm rate,
P(S/n), where P represents probability, S represents diagnosis of a disorder, and s and n
represent presence or absence of a disorder, respectively (Treisman & Faulkner, 1984).
In other words, the researcher plots sensitivity as a function of (1 – specificity). This
produces a curve that allows for the determination of the optimal cut point for diagnosis.
According to Dobie et al. (2002), a ROC curve will have an ―initial steep section where
sensitivity increases while the false positive rate (1 - specificity) changes only minimally.
This is followed by a bend in the curve, then a flattened section where the false positive
rate increases rapidly with little improvement in sensitivity (p. 369).‖ The ROC curve is
used to determine the optimal cut point score that maximizes the detection of true
positives and true negatives. This cut score is the sensitivity/(1 - specificity) value found
at upper left corner of the curve (Dobie et al., 2002).
According to Youngstrom et al. (2001), the accuracy of the ROC can be
determined by calculating the area under the curve or AUC. The area under the curve,
referred to by Swets (1988) as A or Az, denotes the amount of discrimination between true
and false positives. This value also provides a natural summary of the test’s overall
diagnostic efficiency (Blume, 2009). When true and false positives are equal, the area
under the curve will be 0.50 and is represented by a diagonal line dividing the total area
in half, indicating no discrimination (Swets, 1988). In other words, the test measure is
performing no better than chance. An AUC of 1.0 would identify perfect discrimination,
so the line would trace the left vertical axis and the upper horizontal axis (Swets, 1988).
Swets concluded that AUCs of .50 - .70 show low accuracy, AUCs of .70 - .90 show
medium accuracy, while AUCs of .90 - 1.00 show high accuracy. Figure 3 shows a
14

sample ROC curve for two PTSD measures, with the first substantially outperforming the
second.

Figure 3. Sample Receiver Operating Characteristic (ROC) curves for two
measures of PTSD.
A decision criterion for an instrument will depend on prior probabilities of true
and false positives (Swets, 1988). A bias exists in diagnostic efficiency measures
because of an instrument’s tendency to favor a certain diagnostic alternative (Swets,
1988). For example, a diagnostic instrument such as the CPS – M is designed to test for
the presence of PTSD symptoms, so it is biased toward true positives. This bias provides
the rationale for converting raw frequencies to proportions, as shown in Figure 2. These
proportions take into account the population estimates, referred to as prior probabilities,
of positive and negative events, or diagnoses. Swets recommended adopting a lenient
criterion for events that have high prior probabilities. For example, if positive diagnosis
has a high probability in the population, the instrument should employ a lenient criterion
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for positive diagnosis. However, the decision criterion will also depend on the possible
costs and benefits associated with correct and incorrect outcomes (Swets, 1988). In
situations where the cost associated with false negatives is high, the decision criterion
will be lenient, while situations with high costs for false positives would imply a strict
criterion. For example, the cost of predicting a malignant cancer that does not occur (false
positive) is small relative to the cost of failing to detect the cancer (false negative).
Conversely, performing a dangerous operation on a patient who turns out to not have a
disease (false positive) has very high costs (Swets, 1988). As Swets, Tanner, and Birdsall
(1961) noted, the four probabilities are interdependent. An increase in the probability of a
hit can be achieved only by accepting an increase in the probability of a false alarm, and
decreases in the other probabilities. Thus, a given criterion yields a particular balance
among the probabilities of the four possible outcomes. In addition, the balance desired
by an observer in any instance will determine the optimal location of his criterion. This
makes it necessary to find the optimum point that balances hits and misses.
Swets (1998) lists two challenges inherent in signal detection theory. Type I
challenges involve balancing hits and misses. Type II challenges involve maximizing
accuracy. With regard to the former, the ROC curve establishes the threshold of evidence
across a variety of test cut scores that allows the instrument to maximize accurate
diagnostic decisions (Swets, 1988). With regard to Type II challenges, ROC analysis
plots the balance between specificity and sensitivity as a function of changing cut scores
in the test instrument, producing a curve that shows the optimal position for efficient
signal detection (Treisman & Faulkner, 1984; Youngstrom et al., 2001).
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Prior Signal Detection Work
Signal detection comparing the CAPS to other PTSD measures. The CAPS
has been used as the criterion in several signal detection studies. These studies provide
excellent examples of the methodology that was employed in the current study. They
also provide a benchmark against which the performance of the CPS-M may be
compared. Prior signal detection studies have included the PTSD Checklist, both the
original (PCL) and civilian (PCL-C) versions, the Impact of Events Scale, the Mississippi
Scale for Combat-Related PTSD, the Penn Inventory for PTSD, the PTSD Symptoms
Scale-Interview Version (PSS-I), the Traumatic Stress Symptoms Checklist (TSSC), and
the Short PTSD Rating Interview (SPRINT). Several studies focused on examining the
diagnostic efficiency of brief screening instruments for PTSD. The diagnostic efficiency
of the CAPS was also assessed when comparing face-to-face to videoconferencing
administrations (Porcari et al., 2009). Following this review of the literature, Table 1
provides a list of these studies and the diagnostic efficiency of the respective instruments,
compared to the CAPS.
PTSD Checklist. Several studies have examined the diagnostic efficiency of both
the original PTSD Checklist (PCL; Weathers et al., 1993) and the civilian version of the
PCL (PCL-C; Weathers, Litz, Huska, & Keane, 1994). To date, no studies were found
that used the CAPS as a gold standard against which to assess the diagnostic efficiency of
the military version of the PCL (PCL-M; Weathers, Huska, & Keane, 1991).
PTSD Checklist (PCL). Blanchard, Jones-Alexander, Buckley, and Forneris
(1996) administered the CAPS and PTSD Checklist (PCL) to 40 motor vehicle accident
and sexual assault victims. The PCL was mailed to participants prior to the CAPS
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interview, and participants were instructed to complete the PCL and bring it to the
interview. Participants then completed a CAPS interview. All interviews were tape
recorded, and 19 were rescored by an independent judge who was blind to the original
diagnosis. The kappa for agreement between judges was .84, p < 0.001. The correlation
between the PCL and the CAPS was .93, and overall diagnostic efficiency was 0.90.
Using a cut-off score of 44 yielded a sensitivity of .94 and a specificity of .86 (Blanchard
et al., 1996). Blanchard et al. recommended using the PCL as a screening instrument for
posttraumatic stress disorder based on its excellent agreement with the CAPS.
Forbes, Creamer, and Biddle (2001) studied 97 male veterans who completed a
questionnaire battery and the CAPS at admission to a twelve-week treatment program.
The first four weeks of the program were inpatient and the remaining eight weeks
consisted of one day of outpatient treatment per week. Participants were followed up at
nine months post-treatment with the CAPS and PCL. The CAPS-PCL correlations
were .30 at intake and .62 at follow-up. Overall diagnostic efficiency at intake was .81
with a reported sensitivity reported to be .98. Specificity was not reported for intake
scores. At follow-up, a cut-off score of 50 yielded sensitivity of .91, specificity of .40,
and overall diagnostic efficiency of .80 (Forbes et al., 2001).
Grubaugh, Elhai, Cusack, Wells, and Frueh (2007) examined the diagnostic
efficiency of the PCL relative to the CAPS in a sample of 44 community mental health
patients. They reported overall efficiency of .76, sensitivity of .69, and specificity of .78
using a cut score of 54 (Grubaugh et al., 2007). Grubaugh et al. found positive and
negative predictive power values of .82 and .64, respectively.
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The diagnostic efficiency of the PCL relative to the CAPS was also examined in a
clinical sample of adults age 65 or older (Hudson, Beckford, Jackson, & Philpot, 2008).
Using the recommended cut score of 50, Hudson et al. (2008) found sensitivity of .40,
specificity of .97, and positive predictive value of .57. However, an optimal cut point of
36 resulted in values of .90, .87, and .45, respectively (Hudson et al., 2008). Hudson et al.
determined that the PCL was an acceptable screening measure in older adults when an
adjusted cut point was used.
Ventureyra, Yao, Cottraux, Note, and Mey-Guillard (2002) administered the
CAPS and a French translation of the PCL to a group of 113 outpatients with PTSD and
31 nonclinical control participants. All participants completed the PCL, Beck Depression
Inventory, Fear Questionnaire, and the Hamilton Rating Scale of Anxiety. Scores on the
PCLS were compared to CAPS interview ratings. Using a cutoff score of 44
(recommended by Blanchard, Jones-Alexander, Buckley, & Forneris, 1996) they
obtained a sensitivity of .97 and specificity of .87 (Ventureyra et al., 2002). Overall
diagnostic efficiency of the PCL was .94.
Walker, Newman, Dobie, Ciechanowski, and Katon (2002) studied diagnostic
efficiency of the PCL relative to the CAPS in a sample of 1225 women enrolled in a staff
model HMO. All participants completed the PCL, and 261 were also administered the
CAPS. In order to screen for childhood trauma, participants completed the Childhood
Trauma Questionnaire. Using a cut-off score of 30, Walker et al. (2002) found optimal
sensitivity of .82 and specificity of .76. Although this cut score is lower than those
previously reported, the authors indicated that this may have been due to use of a sample
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with a more limited trauma history than in previous studies (Walker et al., 2002). Thus, a
lower cut score may produce more optimal diagnostic efficiency in a sub-clinical sample.
In summary, the studies assessing the utility of the PCL relative to the CAPS
reported overall diagnostic efficiencies ranging from .76 to .94 (Grubaugh et al., 2007;
Ventureyra et al., 2002). Sensitivity scores ranged from .40 to .98 (Hudson et al., 2008;
Forbes et al., 2001), and specificity scores were between .40 and .97 (Forbes et al., 2001;
Hudson et al., 2001). Recommended cut-off scores ranged from 30, which produced
sensitivity of .82 and specificity of .76 (Walker et al., 2002), to 54, which resulted in
sensitivity of .69 and specificity of .78 (Grubaugh et al., 2007). A cut-off score of 44,
utilized by Ventureyra et al. (2002), resulted in the highest diagnostic efficiency statistics,
with overall efficiency of .94, sensitivity of .97, and specificity of .87.
PTSD Checklist – Civilian version (PCL-C). In order to assess diagnostic
efficiency of the PTSD Checklist – Civilian version (PCL-C), Bollinger, Cuevas,
Vielhauer, Morgan, and Keane (2008) examined the diagnostic efficiency of the PTSD
Checklist-Civilian version (PCL-C) in a sample of HIV seropositive individuals. Using a
cut point of 52, they reported overall diagnostic efficiency of .82, but sensitivity was .71
and specificity was .84 (Bollinger et al., 2008). The recommended cut point of 50
yielded the optimal balance between sensitivity and specificity, at .86 and .79,
respectively (Bollinger et al., 2008).
Dobie et al. (2002) administered the PCL-C and the CAPS to 282 female veterans.
Prior to the CAPS administration, participants completed the PCL and other self-report
questionnaires designed to evaluate their overall quality of life. They then completed the
Alcohol Use Disorder and Associated Disabilities interview to assess for the presence of
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substance use disorders. Finally, participants were administered the CAPS by a trained
clinician. A ROC analysis found an AUC of .86. Using an optimal cut-point score of 38,
sensitivity was .79 and specificity was .79 (Dobie et al., 2002).
Lang, Laffaye, Satz, Dresselhaus, and Stein (2003) administered the PCL-C and
the CAPS to a sample of 419 women at the San Diego VA Healthcare System.
Participants also completed the SF-36 (Ware & Sherbourne, 1992), a short questionnaire
designed to measure health-related quality of life. Employing the recommended cut-off
score of 50, they found overall diagnostic efficiency of .74, sensitivity of .39, and
specificity of .74. These statistics were lower than those reported in other signal
detection studies using a cut-off of 50 on the PCL-C. When Lang et al. used a cut-off of
28, they found overall efficiency of .78, sensitivity of .94, and specificity of .68. They
concluded the PCL-C was an adequate screening measure of PTSD symptoms in a
population of female veterans.
In summary, the studies assessing the utility of the PCL-C relative to the CAPS
reported overall diagnostic efficiencies ranging from .74 to .86 (Lang et al., 2003; Dobie
et al., 2002). Sensitivity scores ranged from .39 to .94 (Lang et al., 2003; Lang et al.,
2003), and specificity scores were between .68 and .84 (Lang et al., 2003; Bollinger et al.,
2008). Recommended cut-off scores ranged from 28, which produced sensitivity of .94
and specificity of .68 (Lang et al., 2003), to 52, which resulted in sensitivity of .71 and
specificity of .84 (Bollinger et al., 2008). Bollinger et al. (2008) reported the highest
balance of sensitivity and specificity at .86 and .79, respectively, using a cut score of 50.
However, they did not report overall efficiency using this cut score. A cut-off score of 38,

21

utilized by Dobie et al. (2002), resulted in the highest diagnostic efficiency statistics, with
overall efficiency of .86, sensitivity of .79, and specificity of .79.
Impact of Events Scale (IES). Coffey, Gudmundsdottir, Beck, Palyo, and Miller
(2006) examined the diagnostic efficiency of the Impact of Events Scale and the PTSD
Symptoms Scale-Self Report relative to the CAPS in a sample of 229 motor accident
survivors. For the IES, Coffey et al. (2006) reported overall diagnostic efficiency of .80,
with a sensitivity of .91 and specificity of .72 using a cut score of 27. According to
Coffey et al., this cut score is somewhat lower than those in studies of other trauma
populations.
Neal, Hill, Hughes, Middleton, and Busuttil (1995) used the CAPS as the criterion
against which to measure several other PTSD scales in a sample of World War II Far East
prisoners of war. Thirty participants completed the Impact of Events Scale, the MMPIPTSD subscale, and the Mississippi Scale for Combat-Related Stress Disorder. They
were then administered the CAPS by trained clinicians. Neal et al. (1995) found that the
Mississippi Scale correlated .81 with the CAPS, and the MMPI-PTSD subscale
correlated .71. A cut-off score of 81 on the Mississippi Scale produced optimal
sensitivity (.78) and specificity (.57). An MMPI-PTSD subscale cutoff of 17 yielded
slightly higher levels of sensitivity (.89) and specificity (.62). Results for the Impact of
Events scale were less impressive. A cutoff of 35 produced sensitivity of .67 and
specificity of .57 (Neal et al., 1995). Overall diagnostic efficiency scores were not
reported for any of the instruments in this study.
Sondergaard, Ekblad, and Theorell (2003) compared the Health Leaflet, a
screening procedure, to the Impact of Event Scale-22 (IES-22), the Harvard Trauma
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Questionnaire (HTQ), and the CAPS. Participants were 86 recently resettled refugees
from Iraqi ethnic groups who were interviewed by social workers. Sondergaard et al.
(2003) found that a cut-off score of 77.5 on the HTQ yielded a sensitivity of .80 and
specificity of .78. A cut-off of 65 on the IES-22 produced sensitivity of .72 and
specificity of .71.
In summary, sensitivity scores for the original Impact of Events Scale ranged
from .67 to .91 (Neal et al., 1995; Coffey et al., 2006). Specificity scores ranged from .57
to .72 (Neal et al., 1995; Coffey et al., 2006). Only the Coffey et al. (2006) study
reported overall diagnostic efficiency at .80. The revised scale demonstrated moderate
diagnostic efficiency in the Sondergaard et al. (2003) study, higher than that reported for
the IES in the Neal et al. (1995) study and lower than that found by Coffey et al.. Overall,
results for the IES do not appear to be as good as those reported for the PCL.
Mississippi Scale for Combat-Related PTSD (Mississippi Scale). Weathers et al.
(1996) plotted the quality of sensitivity against the quality of specificity for the
Mississippi Scale, the War-Zone PTSD Scale, and the Keane PTSD Scale of the MMPI
(PK Scale). They determined PTSD diagnosis by administering either the PTSD module
of the Structured Clinical Interview for DSM-III-R (SCID; Spitzer, Williams, Gibbon, &
First, 1990) or the CAPS. The authors determined that the Mississippi Scale was the best
PTSD predictor, as evidenced by this scale’s overall diagnostic efficiency of .83,
sensitivity of .83, and specificity of .83, using a cut score of 109 (Weathers et al., 1996).
They also reported that the Spearman rank point-biserial correlation (rpb) between the
Mississippi Scale and the interview diagnosis was .69. This correlation equals the
proportion of area under the ROC curve and measures the overall quality of the scale
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(Weathers et al., 1996). This was higher than correlations for the WZ-PTSD scale and
the PK Scale, which were .62 and .57, respectively.
Penn Inventory for PTSD. Another study that used the CAPS as a criterion was
performed by Scragg, Grey, Lee, Young, and Turner (2001). The Penn Inventory for
PTSD was administered to a group of 80 males and females referred to an outpatient
clinic for trauma in the UK. In addition to completing the Penn Inventory and the CAPS
assessment, participants also completed the General Health Questionnaire-28 (GHQ-28;
Goldberg & Hillier, 1979), the Beck Depression Inventory (BDI; Beck et al., 1961), and
the Beck Anxiety Inventory (BAI; Beck & Steer, 1993). Relative to the CAPS, the Penn
Inventory had an overall diagnostic efficiency of .81 for male participants and .83 for
females, using a cut score of 35. Sensitivity was .90 and .89 for males and females,
respectively. Specificity was .55 for males and .67 for females. Scragg et al. (2002)
recommended using the Penn Inventory as a screening measure to assess mental wellbeing after a trauma, rather than as a diagnostic tool.
PTSD Symptoms Scale. Coffey et al. (2006) examined the diagnostic efficiency
of the PTSD Symptom Scale-Self Report (PSS-SR) and the Impact of Events Scale
relative to the CAPS in a sample of 229 motor accident survivors. For the PSS-SR,
Coffey et al. reported overall diagnostic efficiency of .74, with a sensitivity of .91 and
specificity of .62 using a cut score of 14. According to Coffey et al., this cut score is
consistent with those in studies of other trauma populations.
Foa and Tolin (2000) compared the PTSD Symptom Scale-Interview Version
(PSS-I), the CAPS, and the SCID. Participants were 64 clinical and non-clinical adult
volunteers from a community sample. They were administered the PSS-I, the CAPS, and
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the Structured Clinical Interview for DSM-III-R (SCID) in counterbalanced order. Foa
and Tolin (2000) used liberal, moderate, and conservative scoring rules recommended by
Blanchard et al. (1995) and Weathers et al. (1999). For the CAPS, they found that using
either the moderate scoring rule proposed by Weathers et al. or the conservative scoring
rule proposed by Blanchard et al. yielded overall diagnostic agreement of .88, sensitivity
of .71, and specificity of .94 relative to the SCID. For the PSS-I, they found overall
agreement of .80, sensitivity of .86, and specificity of .78 compared with the SCID.
Based on these results, they concluded that the CAPS yielded better overall agreement
and specificity, while the PSS-I produced better sensitivity for PTSD diagnosis.
Traumatic Stress Symptoms Checklist (TSSC). Basoglu et al. (2001) assessed
the validity of the Traumatic Stress Symptoms Checklist (TSSC) in a sample of 130
earthquake survivors in Turkey. They compared diagnoses based on the CAPS and the
Major Depressive Episode module of the Semistructured Clinical Interview for DSM-IV
(SCID: First, Spitzer, Gibbon, & Williams, 1996). The authors found a cut-off of 25 on
total scores of 17 PTSD items to yield optimal sensitivity of .81 and specificity of .81.
The authors found that the TSSC demonstrated satisfactory sensitivity and specificity in
providing a diagnosis of PTSD (Basoglu et al., 2001).
Short Post-Traumatic Stress Disorder Rating Interview (SPRINT). Kim et al.
(2008) assessed the diagnostic efficiency of the Korean version of the Short PostTraumatic Stress Disorder Rating Interview (K-SPRINT). They administered a packet
consisting of the K-SPRINT, CAPS, Beck Depression Inventory (BDI), and State Trait
Anxiety Inventory (STAI) to a sample of 197 individuals. A cut score of 15 resulted in
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overall efficiency of .92, sensitivity of .91, and specificity of .93, suggesting that the KSPRINT is a good diagnostic measure of PTSD in this population (Kim et al., 2008).
Brief screening instruments. Kimerling, Ouimette, et al. (2006) administered
Breslau’s 7 item PTSD screen (Breslau et al., 1999) to 134 patients recruited from VA
medical center primary care clinics to determine its diagnostic efficiency relative to the
CAPS. Kimerling, Ouimette, et al. (2006) determined that a cut score of 4 resulted in
optimal sensitivity of .85 and specificity of .84.
Kimerling, Trafton, and Nguyen (2006) assessed the diagnostic efficiency of a 4item screen for PTSD, the Primary Care PTSD Screen (PC-PTSD), relative to the CAPS
in a sample of 97 patients recruited from substance abuse clinics at a VA medical center.
A cutoff score of 3 resulted in optimal overall efficiency of .84, sensitivity of .91, and
specificity of .80 (Kimerling, Trafton, et al., 2006). Positive and negative predictive
values using this cut score were .69 and .95, respectively (Kimerling, Trafton, et al.,
2006).
CAPS administered face-to-face and via teleconferencing. Porcari et al. (2009)
administered the CAPS to twenty male veterans seeking mental health services for PTSD.
The CAPS was administered both face-to-face and via teleconferencing. They found
significant correlations, ranging from .74 (subscale C: avoidance/numbing) to .92
(subscale B: reexperiencing), between the two assessment methods on the subscales and
total severity scores. Confidence interval analysis revealed statistical equivalence
between the two methods, and signal detection analysis resulted in overall diagnostic
efficiency of .85, sensitivity of .94 and specificity of .33, suggesting a moderate
agreement between the two methods (Porcari et al., 2009).
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Summary of studies. Diagnostic efficiency of the PCL relative to the CAPS
ranged from .76 to .94 (Grubaugh et al., 2007; Ventureyra et al., 2002). PCL-C
efficiencies ranged from .74 to .86 (Lang et al., 2003; Dobie et al., 2002). Overall
efficiency for the Impact of Events Scale was .80 in a study by Coffey et al. (2006), and
sensitivity scores were .67 and .91 according to Coffey et al. and Neal et al. (1995),
respectively. Reported specificities were .57 (Coffey et al., 2006) and .72 (Neal et al.,
1995). Sondergaard et al. (2003) reported sensitivity of .72 and specificity of .71 for the
Impact of Event Scale-22 in a sample of refugees.
Diagnostic efficiency of the Penn Inventory for PTSD relative to the CAPS
was .81 for males and .83 for females in an outpatient trauma clinic (Scragg et al., 2001).
Foa and Tolin (2000) reported overall efficiency of .80 for the PTSD Symptom Scale –
Interview Version, and Coffey et al. (2006) reported overall diagnostic efficiency of .74,
with a sensitivity of .91 and specificity of .62 for the PTSD Symptom Scale – Self Report.
The Traumatic Stress Symptoms Checklist was compared to the CAPS and produced
sensitivity of .81 and specificity of .81 in a sample of earthquake survivors (Basoglu et al.,
2001). Kimerling, Trafton, et al. (2006) reported overall efficiency of .84, sensitivity
of .91, and specificity of .80 on the Primary Care PTSD Screen (PC-PTSD), and
Kimerling, Ouimette, et al. (2006) found optimal sensitivity of .85 and specificity of .84
on Breslau’s 7 item PTSD screen. Finally, Porcari et al. (2009) administered the CAPS
both face-to-face and via teleconferencing and reported overall efficiency of .85,
sensitivity of .94, and specificity of .33.
Not all signal detection studies reported overall diagnostic efficiency and fewer
still reported AUC data. Some reported sensitivity and specificity scores, while others
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included Spearman rank point-biserial correlations or positive predictive power values.
Other studies included the cut scores that yielded the optimal sensitivity and specificity.
According to Youngstrom et al. (2001), sensitivity and specificity are theoretically
independent of base rates, making them better than positive or negative predictive power
in terms of generalizability to other samples. As such, the focus of the current study will
be on diagnostic efficiency as measured by sensitivity, specificity, and the area under the
curve (AUC). The optimal cut score will also be reported, as cut scores are crucial in
determining an instrument’s threshold for accurate diagnosis within a given population.
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Table 1
Signal Detection Studies Using the CAPS as the Diagnostic Criterion

Study

Population

Test Instrument(s)
PTSD Checklist

Results

Blanchard et

40 motor vehicle

al. (1996)

accident and sexual

= .90. Sensitivity = .94, specificity = .86

assault victims

with cut score of 44.
PTSD Checklist

PCL-CAPS r = .93, diagnostic efficiency

Forbes et al.

97 Vietnam veterans

At intake, PCL-CAPS r = .30, diagnostic

(2001)

with combat-related

efficiency = .81.

PTSD

At 9-month follow-up, PCL-CAPS r
= .62, sensitivity = .94, specificity = .20
with cut score of 45.

Grubaugh et

44 traumatized

PTSD Checklist

Diagnostic efficiency = 76, sensitivity

al. (2007)

community mental

= .69, specificity = .78, positive

health patients

predictive power = .82, negative
predictive power = .64.

Hudson et al.

Clinical sample of

(2008)

adults age 65 or older

PTSD Checklist

Sensitivity = .40, specificity = .97,
positive predictive power = .57 with cut
score of 50; sensitivity = .90, specificity
= .87, positive predictive power = .45
with cut score of 36.

Ventureyra et

113 outpatients

French translation

Sensitivity = .97, specificity = .87,

al. (2002)

suffering from PTSD,

of PTSD Checklist

diagnostic efficiency = .94 with cut score

compared to 31

of 44.

nonclinical controls
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Study

Population

Test Instrument(s)

Walker et al.

1225 women enrolled

(2002)

in a staff model HMO

Bollinger et

HIV seropositive

PTSD Checklist-

Diagnostic efficiency = .82, sensitivity

al., (2008)

individuals

Civilian Version

= .71, and specificity = .84, cut score 52;

PTSD Checklist

Results
Sensitivity = .82, specificity = .76, cut
score 30.

sensitivity = .86, and specificity = .79,
cut score 50.
Dobie et al.

282 female veterans

(2002)
Lang et al.

419 female veterans

(2003)

PTSD Checklist –

Sensitivity = .79, specificity = .79 with

Civilian version

cut score 38. AUC = .86.

PTSD Checklist –

Diagnostic efficiency = .78, sensitivity

Civilian version

= .94, specificity = .68, cut score 28.

Coffey et al.

229 motor vehicle

Impact of Events

IES overall diagnostic efficiency = .80,

(2006)

accident survivors

Scale

sensitivity = .91, specificity = .72, cut
score 27.

Neal et al.

30 World War II Far

Impact of Events

IES sensitivity = .67, specificity = .57,

(1995)

East prisoners of war

Scale

cut score 35.

Sondergaard

86 refugees from

Impact of Event

IES-22-CAPS sensitivity = .72,

et al. (2003)

Iraqi ethnic groups

Scale-22

specificity = .71, cut score 65.

Scragg et al.

80 men and women

Penn Inventory for

Diagnostic efficiency = .81 for men, .83

(2001)

referred to an

PTSD

for women, cut score 35. Sensitivity

outpatient clinic for

= .90 for men, .89 for women.

trauma in the UK

Specificity = .55 for men, .67 for
women.

30

Study
Weathers et

Population
202 Vietnam veterans

Test Instrument(s)
Mississippi Scale

al. (1996)

Results
Sensitivity = .83, specificity = .83,
overall diagnostic efficiency = .83.

Coffey et al.

229 motor vehicle

PTSD Symptom

PSS-SR overall diagnostic efficiency

(2006)

accident survivors

Scale – Self Report

= .74, sensitivity = .91, specificity = .62,
cut score 14.

Foa & Tolin

64 clinical and non-

PTSD Symptom

Diagnostic efficiency = .80, sensitivity

(2000)

clinical adults

Scale-Interview

= .86, specificity = .78, no cut score
reported.

Basoglu et al.

130 earthquake

Traumatic Stress

Sensitivity = .81, specificity = .81, cut

(2001)

survivors in Turkey

Symptoms

score 25.

Checklist
Kim et al.

197 patients; 87

Korean version of

Diagnostic efficiency = .92, sensitivity

(2008)

PTSD, 47 other, 63

the Short PTSD

= .91, and specificity = .93, cut score 15.

controls

Rating Interview

Kimerling,

134 VA primary care

Breslau’s 7 item

Sensitivity = .85, specificity = .84, cut

Ouimette, et

patients

PTSD screen

score 4.

Kimerling,
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Signal detection comparing other PTSD instruments. Despite the fact that the
CAPS is considered the ―gold standard‖ in PTSD research, some studies have employed
other instruments as the criterion against which to measure new PTSD assessment
instruments. These criterion instruments have included a Chinese version of the Startle,
Physiological Arousal, Anger, and Numbness scale (C-SPAN), the PTSD Checklist
(PCL), the war-zone related PTSD scale (WZ-PTSD), and the SCID.
Chen, Shen, Tan, Chou, and Lu (2003) compared a Chinese version of the SPAN
(C-SPAN) to a Chinese version of the Davidson Trauma Scale (DTS-C). The authors
assessed 210 earthquake survivors of the 1999 Chi-Chi Earthquake. Chen et al. (2003)
calculated diagnostic efficiency statistics based on varying cut points, and these statistics
ranged from .33 to .98 for sensitivity and .43 to .94 for specificity. A cut score of 5 on
the C-SPAN resulted in the highest overall efficiency at .80, as well as optimal sensitivity
(.79) and specificity (.80).
The PTSD Checklist (PCL) was used as the criterion against which to assess the
psychometric properties of the Impact of Events Scale-Revised (Creamer, Bell, &
Familla, 2003). The authors administered the instruments to two samples of Vietnam
veterans. One group was a treatment-seeking sample with confirmed PTSD (N = 120),
and the other was a community sample with varying symptomatology (N = 154). Using
total sample scores, the two scales were highly correlated (r = .84), and a cutoff on the
PCL of 33 resulted in overall efficiency of .88, sensitivity of .91, and specificity of .82
(Creamer et al., 2003).
Weathers et al. (1996) developed a scale for assessing war-zone related PTSD
(WZ-PTSD scale). In a psychometric study comparing the WZ-PTSD scale to the
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Symptom Checklist-90-R, the instrument from which it was derived, the authors
administered these two instruments, as well as several other convergent measures, to 202
male Vietnam veterans. These convergent measures included either the PTSD module of
the Structured Clinical Interview for DSM-III-R (SCID) or the CAPS, the Mississippi
Scale for Combat-Related PTSD, and either the MMPI or the MMPI-2. The Mississippi
Scale demonstrated the highest overall efficiency (.83), followed by the WZ-PTSD. The
WZ-PTSD demonstrated moderate sensitivity (.90) and specificity (.65) (Weathers et al.,
1996).
Using an adaptation of the CAPS designed to assess schizophrenia (CAPS-S),
Gearon, Bellack, and Tenhula (2004) reported diagnostic efficiency statistics relative to
the SCID. Nineteen women with schizophrenia and drug use were administered the
CAPS-S, the SCID, and the Impact of Events Scale. Gearon et al. (2004) reported overall
efficiency of .78, sensitivity of .50, and specificity of 1.00. However, their small sample
size significantly limited the generalizability of these findings.
Signal detection comparing psychological instruments outside of PTSD. As
signal detection is a methodology ideally suited to comparing instruments and
determining the diagnostic power of new instruments, it has been used in other domains
of pathology. Studies employing signal detection in other domains will be briefly
reviewed, as they provide further examples of ―normal‖ performance of psychological
instruments.
Signal detection has been used to evaluate the efficiency of measures assessing
college maladjustment, adolescent psychiatric difficulties, substance abuse, depression,
and bipolar disorder. Diagnostic efficiency statistics reported in these domains have been
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similar to those found for PTSD instruments. Additionally, many studies have used
signal detection techniques to evaluate the DSM-IV diagnostic criteria for attentiondeficit/hyperactivity disorder (Mota & Schachar, 2000), autism (Siegel, Vukicevic, &
Spitzer, 1990), and personality disorders (Farmer & Chapman, 2002; Fossati et al., 2005;
Grilo, 2004; Grilo, Becker, Anez, & McGlashan, 2004). While these studies utilize
signal detection techniques, their methodologies are very different from that being
employed in this study.
Lauterbach, Garcia, and Gloster (2002) performed a psychometric study of the
College Maladjustment Scale (Mt), a supplementary scale of the Minnesota Multiphasic
Personality Inventory (MMPI-2). In addition to the Mt scale, they administered the
Academic Performance Questionnaire, the Shipley Institute of Living Scale, the
Traumatic Events Questionnaire (TEQ), and the PTSD Checklist-Civilian (CL-C) to 473
undergraduate students. Lauterbach et al. (2002) reported that a cut score of 29 or higher
resulted in the best overall diagnostic utility. Diagnostic utility scores were .62 for
individuals currently in therapy, .53 for individuals with a history of three or more
therapy sessions, and .87 for individuals with a PTSD diagnosis (Lauterbach et al., 2002).
Pinto and Grilo (2004) administered selected scales from the Millon Adolescent
Clinical Inventory (MACI) to 241 hospitalized adolescents. Scores on the MACI were
compared to independent DSM-IV clinical discharge diagnoses. MACI scale diagnostic
efficiency statistics ranged from .17 to .71 for sensitivity and from .40 to .93 for
specificity, depending on the scale and the cut score used. The scale with the highest
diagnostic efficiency was ―substance abuse proneness,‖ which demonstrated sensitivity
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of .61 and specificity of .82 with a diagnosis of ―drug use disorder,‖ using a cut score of
75 (Pinto & Grilo, 2004).
The Neuropsychological Assessment Battery-Screening Module (NAB-SM) and
the Neuropsychological Screening Battery (NSB) were administered to 84 substance
abuse patients entering residential treatment (Grohman & Fals-Stewart, 2004). Using the
NSB as the criterion, the authors found overall diagnostic efficiency of .88, sensitivity
of .81, and specificity of .92, indicating excellent diagnostic accuracy of the test
instrument.
Youngstrom et al. (2004) compared six potential bipolar disorder screening
instruments to assess which produced best overall diagnostic accuracy. In addition to
participating in the Semistructured Diagnostic Interview Using the Schedule of Affective
Disorders and Schizophrenia for Children, scores were obtained for the 642 participants
(318 aged 5-10; 324 aged 11 to 17) on the Parent Young Mania Rating Scale, the General
Behavior Inventory, the Parent General Behavior Inventory, the Child Behavior Checklist,
the Youth Self-Report, and the Teacher Report Form. Parent report (efficiency from .78
to .84 in both age groups) performed better than teacher report (efficiency of .57 in
younger and .70 in older group) or adolescent measures (efficiencies of .67 and .71 on
General Behavior Inventory and Youth Self-Report, respectively) at accurately
classifying presence of bipolar disorder (Youngstrom et al., 2004).
Huprich, Sanford, and Smith (2002) compared the psychometric properties of the
Depressive Personality Disorder Inventory (DPDI) to other measures of depression. In
addition to the DPDI, they administered the Structured Clinical Interview for DSM-IV
Axis II Disorders for Self-Report (SCID-II), the BDI-II, the Diagnostic Interview for
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Depressive Personality (DIDP), the Early Life Events Questionnaire (ELEQ), the
Provision of Social Relations Scale (PSR), and the Bell Object Relations and Reality
Testing Inventory, Form O (BORRTI). Using the Diagnostic Interview for Depressive
Personality as the criterion, Huprich et al. (2002) found sensitivity of .82, specificity
of .80, and overall diagnostic efficiency of .81 with a cut score of 170 on the DPDI.
Signal detection comparing medical assessment instruments or techniques.
Outside the domain of psychological assessment, signal detection theory has been mostly
used to assess associative recognition, detection of auditory and visual signals, and pitch
recognition. However, there is a sparse collection of literature documenting the use of
signal detection to determine the diagnostic efficiency of medical assessment instruments
and techniques.
McNally et al. (2009) used signal detection theory to examine methods of
classifying patients as having psychogenic nonepileptic seizures versus epileptic seizures
using the Wechsler Memory Scale, Third Edition, Word List Test (WMS-III WLT) as the
criterion. They reported sensitivity of .59 and specificity of .62 for the logistic regression
method, .52 and .74, respectively, for the routine interictal EEG, and .60 and .84,
respectively, for the method using the MMPI Scales 1 and 3. Other signal detections
studies have examined automated cytology (Narayanswamy & Johnson, 1998), hepatitis
C, and HIV (Dragoni et al., 2005).
Diagnostic Efficiency of the CPS-M in a College Student Sample
The present study replicated an earlier phase of this project (Mainka, 2005). The
previous phase assessed the diagnostic efficiency of the CPS-M in a college student
sample reporting a trauma history. Participants were college students who were screened
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for the presence of PTSD. Individuals who endorsed a score of 35 or higher on the
Impact of Events Scale were included in the study, and participants were grouped into
two severity groups based on these scores: moderate and high.
The CPS-M was compared to the CAPS to establish diagnostic efficiency. If an
instrument is efficient at diagnosing PTSD, it should agree with the criterion most of the
time. There were substantial interrelationships between the CAPS and the CPS-M.
Pearson Product-Moment correlations revealed that all items and subscales were
significantly correlated. Criterion B items on the CPS-M correlated strongly with
Criterion B items on the CAPS and ranged from .42 to .82. Subscale B of the CPS-M
was correlated .86 with subscale B on the CAPS. Individual items comprising Criterion
C on the CPS-M were correlated strongly with CAPS Criterion C items, ranging from .42
to .89. Subscale C of the CPS-M was significantly correlated with subscale C of the
CAPS (r = .89). The correlation between the Criterion D CPS-M items and the
corresponding Criterion D CAPS items ranged from .55 to .88. The criterion D subscale
scores from the two instruments were also significantly correlated (r = .84). Total
Severity Scores on the CPS-M and CAPS were also significantly correlated at .92. High
correlations indicate strong associations at the item and scale levels. These findings are
not surprising given that the CPS-M was modeled after the CAPS.
The CAPS and CPS-M subscale and total scores were correlated with scores on
the Purdue PTSD Scale and the Civilian Mississippi Scale (C-MISS; Kulka et al., 1990).
Results showed that the CAPS and CPS-M obtained remarkably similar correlations with
the convergent validity measures. CAPS subscale correlations with Purdue PTSD Scale
subscales and total were .65, .74, .74 and .85 for Criteria B, C, D, and total score,
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respectively. CPS-M subscale correlations with Purdue PTSD Scale subscales and total
were .76, .74, .69 and .86 for Criteria B, C, D, and total score, respectively. CAPS
correlations with the Civilian Mississippi Scale subscales and total were .42, .69, .68
and .72 for Criteria B, C, D and total score, respectively. CPS-M correlations with the
Civilian Mississippi Scale subscales and total were .48, .63, .62 and .68 for Criterion B, C,
D and total score, respectively.
Alpha for the full scale was .86, indicating good internal consistency. With the
exception of items C3 (psychogenic amnesia) and D1 (sleep disturbance), removal of an
item from the scale resulted in a lower alpha coefficient. Alpha coefficients for the CPSM subscales were .86 for Criterion B, .75 for Criterion C, and .48 for Criterion D.
As an initial strategy for comparing subscale scores obtained by the CAPS and the
CPS-M, effect sizes were computed. Analysis of effect sizes of mean scale differences
revealed very small negative effect sizes for Criteria B and C and positive effect sizes for
Criterion D and Total Severity Score on the CPS-M. None of the effect sizes exceeded a
fifth of a standard deviation. Small effect sizes suggested very little mean difference in
CPS-M and CAPS scores.
Using the Rogers et al. (1993) method, confidence interval testing results
suggested none of the CAPS and CPS-M scales were equivalent. However, none of the
scales were significantly different. This resulted in a classification of ―Not Different and
Not Equivalent‖ for all of the CPS-M scales. Given the lack of research regarding
optimal equivalence range for assessment instruments, Mainka (2005) theorized that
equivalence intervals of ± 20% may be more realistic in terms of the ultimate effects of
scores on clinician inferences. If an equivalence range is so narrow that clinician
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inferences are no different if the equivalence interval is exceeded, then a justification of
the width of the interval may be needed. The small sample size in the Mainka study (N =
40) influenced standard error of measurement. In addition, it is not clear that these
results would generalize to a clinical population. It could be that the classifications
would change with true PTSD cases.
Next the diagnostic utility of the CPS-M was examined with signal detection
theory. Due to the subclinical sample used in the Mainka (2005) study, only one
symptom presence scoring rule resulted in enough PTSD-positive cases to perform
meaningful signal detection analyses. The CAPS 1-2 symptom presence scoring rule
produced eleven PTSD-positive cases and twenty-five PTSD-negative cases. Signal
detection statistics revealed medium accuracy of the CPS-M in diagnosing PTSD and an
AUC of .78, as demonstrated in Figure 4. A cut score of 45 produced sensitivity of .63
and specificity of .80. Although sensitivity and specificity statistics were lower than
those reported by Neal et al. (1994), the two studies are not directly comparable given the
subclinical sample used by Mainka and the incomplete data reporting of the Neal et al.
study.
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Figure 4. CPS-M ROC curve based on CAPS 1-2 symptom presence scoring rule in the
Mainka (2005) study.
Although the more stringent symptom presence scoring rules were not used in the
signal detection, kappa coefficients showed fair to moderate agreement across scoring
rules. The Total 65 rule resulted in the highest kappa, at 1.00. However, this is not
surprising given that the scoring rule resulted in only one PTSD-positive case. Based on
this, Mainka (2005) determined that future research with a clinical sample should use
more stringent scoring rules to produce meaningful signal detection.
Signal detection revealed that a cut score of 45 produced the best sensitivity and
specificity. Cut scores tend to be very sample-specific, however, and a cut score of 45 in
a nonclinical sample may not be the optimal cut score in a clinical sample. Mainka (2005)
hypothesized that, in a sample with more psychopathology and PTSD-positive cases, the
cut score would most likely need to be raised to produce optimum sensitivity, specificity,
and overall efficiency.
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In the final phase of analysis, the ROC curve of the CPS-M was compared to
ROC curves produced by the Civilian version of the Mississippi PTSD scale and the
Purdue PTSD Scale. It was hypothesized that the ROC curve produced by the CPS-M
would be slightly better or would not be significantly different from those produced by
these other instruments. However, the ROC curves for all the instruments did not
significantly differ from one another. Figure 5 compares all of the ROC curves. This
suggested that the CPS-M was as efficient as other PTSD screening measures in correctly
identifying PTSD and non-PTSD cases. Although there was no difference in detection
efficiency, these results were constrained to just one scoring rule.
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Figure 5. ROC curves for the CPS-M, C-Miss, and Purdue PTSD Scale.
Overall, the findings in the Mainka (2005) study were encouraging regarding the
CPS-M. Correlations between the CAPS and CPS-M were high at the item, subscale, and
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full-scale levels. Confidence interval analysis revealed that the CPS-M scales were not
significantly different from their CAPS counterparts. However, the conservative ± 10%
criterion for equivalence virtually guaranteed that the scales could not be judged
equivalent to their CAPS counterparts. ROC curve analysis for the CPS-M revealed
medium diagnostic accuracy. The CPS-M’s ROC curve was not significantly different
from those of the C-MISS and Purdue PTSD Scale, indicating similar diagnostic
efficiency across measures. Signal detection was limited by the use of only the most
liberal scoring rule to produce PTSD-positive cases. The present study used a clinical
sample in which all scoring rules produced both PTSD positive and negative cases.
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Overview of the Current Study
The current study aimed to accomplish several goals. One goal was to establish
correlational relationships between the CAPS and the CPS – M at the item, subscale, and
total score levels. Another goal was to determine statistical difference and equivalence of
the two measures. The third goal was to examine the diagnostic utility of the CPS – M in
a clinical population and identify the optimum cut point for the CPS – M relative to the
CAPS. The overall efficiency and cut point were determined by the area under the ROC
curve (AUC) for the CPS – M. The final aim was to compare the diagnostic utility of the
CPS – M to several convergent measures when using the CAPS as the criterion. The
convergent validity measures included the PTSD Checklist, the Purdue PTSD ScaleRevised, the Beck Depression Inventory, and the Trauma Related Dissociation Scale.
Because depression and dissociation are very closely related to PTSD, these were
included to compare the CPS-M to measures assessing similar, but not identical,
constructs. The PCL and Purdue Scale were included to evaluate ROC curves of several
PTSD instruments, when compared to the CAPS. Because the CPS-M is modeled after
the CAPS, it was expected that it would be more highly correlated with the CAPS than
with the PCL or Purdue PTSD Scale-Revised, and it would be more strongly associated
with the measures of PTSD than with those assessing depression or dissociation.
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Method
Recruitment of Participants
Participants were drawn from three clinics at a Veterans Affairs Hospital: the
mental health clinic, the PTSD clinic, and primary care. These three clinics were selected
for the purpose of obtaining a heterogeneous sample, and participants from the clinics
were not compared. Participants received a $10 gift card to a local retail store for
completion of the study. Potential participants completed a screening packet that
assessed for the presence of a traumatic event and the severity of post-traumatic
symptomatology.
In order for signal detection to provide a clear picture of diagnostic efficiency, it
is necessary to utilize participants with and without PTSD. To obtain an adequate sample
size, a sample of 90 participants was needed for the study. Of these participants, 45 were
individuals who endorsed a trauma but little or no PTSD symptomatology, as
demonstrated by a score of 34 or lower on the PTSD Checklist. Forty-five were
individuals who endorsed a trauma and reported moderate to high symptom severity, as
evidenced by a score of 44 or higher on the PTSD Checklist. A cut score of 44 yielded
overall efficiency of .90, sensitivity of .94, and specificity of .86 in a sample of motor
vehicle accident and sexual assault victims (Blanchard et al., 1996).
Study Procedure
Potential participants were administered a screening packet (described below)
prior to the test session. Eligible participants then completed one subsequent test session.
During the test session, the CAPS interview and other scales were administered in a quiet
room at the administration site. A trained interviewer performed the CAPS interview.
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The CPS – M was administered via a laptop computer with headphones and a mouse.
Average CPS – M administration time to completion was 30 minutes. The administration
of the CAPS took approximately an hour and a half. Completion of the remaining selfreport questionnaires took approximately 20 minutes. Participants spent approximately
60-150 minutes completing the study. After their session, participants were debriefed
with a written explanation of the study and provided a list of counseling resources in case
of emotional difficulties due to participation in the study (described below).
Training Protocol
In addition to the principal investigator, three research assistants administered
study sessions. Research assistants attended several training sessions on administering
CAPS interviews, where CAPS training modules from the National Center for PTSD
were followed. They then sat in on several interviews performed by the principal
investigator and took the lead while being observed. Additionally, a comprehensive
training manual was created for study procedures, including instructions for recruitment,
obtaining informed consent, and administration of the study session.
Screening Instruments
The screening packet consisted of a cover page (see Appendix A) that asked for
contact information, a Risk Assessment Form (Appendix B) that assessed suicidality and
homicidality, the Life Events Checklist (see Appendix C), and the PTSD Checklist (see
Appendix D). A study Exclusion Form was also completed for each potential participant
(see Appendix E).
Life Events Checklist (LEC). The LEC was included in the screening battery to
assess participants’ history of exposure to traumatic events. The LEC is a 17-item

45

questionnaire developed by the National Center for PTSD. Gray, Litz, Hsu, and
Lombardo (2004) compared the LEC to the Traumatic Life Events Questionnaire (TLEQ)
in a sample of college undergraduates. They reported a mean kappa of .61 across the
seven items assessing direct trauma exposure, as well as adequate agreement with the
TLEQ, r = -.55, p < .001 (lower scores on the TLEQ indicate more exposure). The mean
kappa was .47 for all items, and test-retest reliability was adequate, r = .82, p < .001.
PTSD Checklist (PCL). The PCL is a 17-item self-report checklist that
measures frequency and severity of symptoms. Respondents score symptom intensity
over the two previous weeks. Blanchard et al. (1996) reported overall diagnostic
efficiency relative to the CAPS of .90, sensitivity of .94, and specificity of .94 using a cut
score of 44 in a sample of motor vehicle and sexual assault victims. The kappa for
agreement between judges was .84, p < 0.001. Blanchard et al. (1996) recommended
using the PCL as a screening instrument for posttraumatic stress disorder based on its
excellent agreement with the CAPS. Using a cut-point score of 38, Dobie et al. (2002)
reported sensitivity of .79 and specificity of .79 in a sample of female veterans.
Test Session
After screening, individuals who were eligible for participation had the option of
either completing the test session immediately or were scheduled to return within two
weeks. Participants were excluded if they had not experienced a trauma, were under the
age of 18, had current or life-time history of a formal thought disorder, or voluntarily
declined. Seventeen veterans were excluded based on these criteria.
Before beginning the test session, participants completed an Informed Consent
Form (See Appendix F). The test session consisted of two assessment components: 1)
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CPS-M and paper-and-pencil questionnaires and the 2) CAPS. Components 1 and 2 were
counterbalanced in their administration, with the CPS-M and paper-and-pencil measures
also being counterbalanced within component 1. Half of the participants completed the
CPS-M and paper-and-pencil questionnaires first and CAPS second, while the other half
completed the CAPS first and CPS-M and paper-and-pencil measures second.
The paper-and-pencil questionnaires were used as convergent measures, against
which to evaluate the performance of the CPS-M in diagnosing PTSD. The previous
study, which assessed diagnostic efficiency in a college student sample, required
participants to complete a paper-and-pencil packet with two PTSD questionnaires. In
response to complaints that participants were answering the same questions repeatedly,
the present study only included one PTSD questionnaire as part of the convergent battery
(in addition to the PCL in the screening packet, which was also used as a convergent
measure). Due to the fact that the present study included military participants, the
Civilian version of the Mississippi Scale for PTSD, which was used in the previous study,
was not used. The Purdue PTSD Scale-Revised provided a convergent measure for
PTSD. The other two questionnaires assessed similar constructs: depression and
dissociation.
Test Session Instruments
Paper-and-pencil measures
Demographic Questionnaire (See Appendix G). This form queried participants
about age, sex, employment status, ethnicity, psychiatric history, and other demographic
variables. It was used for determining and reporting descriptives for the present study.
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Purdue Posttraumatic Stress Disorder Scale – Revised (See Appendix H). The
Purdue Scale (Lauterbach & Vrana, 1996) was included in the study to compare its
diagnostic efficiency statistics to those obtained by the CPS - M. The Purdue is a 17-item
scale measuring frequency of PTSD symptoms to produce four scales: Reexperiencing,
Avoidance, Arousal, and Total. Lauterbach and Vrana (1996) found the Purdue Scale to
be highly correlated with other measures of PTSD in a sample of 562 undergraduates.
Lauterbach and Vrana found adequate test-retest reliability over two weeks (r = .72) and
excellent internal consistency (α = .91). They concluded that, due to its ability to
discriminate between people who were and were not traumatized, the PPTSD – R is a
promising measure of PTSD symptoms in a college population.
Trauma Related Dissociation Scale (TRDS) (See Appendix I). The TRDS
(Carlson & Waelde, 1999) is a 24-item questionnaire that assesses five dimensions of
trauma-related dissociation (depersonalization, derealization, gaps in awareness, amnesia,
and gaps in awareness plus reexperiencing). In a sample of 30 outpatients and 62
veterans, Carlson and Waelde (1999) reported internal consistency alphas ranging
from .60 for derealization to .87 for amnesia, with an alpha of .93 for the total score. The
TRDS is significantly correlated with the Dissociative Experiences Scale (DES). The
TRDS-DES correlations ranged from .35 to .55 for subscales, and the total scale
correlation between the DES and TRDS was .56. They also reported a correlation of .51
between the TRDS and the CAPS (Carlson & Waelde, 1999).
Beck Depression Inventory (BDI-II) (See Appendix J). The BDI-II (Beck, Steer,
& Brown, 1996) is a 21-item questionnaire used to assess the severity of depression in
adolescents and adults. It asks questions about the physical, cognitive, and behavioral
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symptoms of depression. This self-report measure is effective in classifying participants
as depressed or nondepressed, and it was included in the study to compare correlations
between the measures assessing PTSD and the measures assessing the similar construct
of depression. The BDI-II has been found to have good internal consistency with values
for coefficient alpha ranging from .90 to .91 (Beck, Steer, Ball, & Ranieri, 1996; Dozois,
Dobson, & Ahnberg, 1998; Osman et al., 1997).
Computerized PTSD Scale – Multimedia Version (CPS – M)
The CPS – M is a computerized version of the CAPS, in which participants
respond to computerized prompts and report frequency and intensity of PTSD symptoms.
Mayo et al. (2000) found that the CPS – M correlated .87 with the Civilian Mississippi
Scale, .79 with the Beck Depression Inventory, .79 with the Beck Anxiety Inventory,
and .13 with the Antisocial Behavior Inventory. Test-retest reliability was .92 for the full
scale, and the alpha coefficient was .91.
Clinician-Administered PTSD Scale (See Appendix K)
The CAPS is a structured interview that provides an assessment of the frequency
and intensity of PTSD symptoms. This was included in the study as the criterion against
which to assess diagnostic agreement of the CPS-M.
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Results
Descriptive Statistics
Participants. One hundred and eight veterans were screened with the LEC and
PCL. Seventeen veterans were screened out of the study due to a variety of reasons.
Eight were screened out due to the presence of a thought disorder, three reported thoughts
of harming self or others and were directly referred for follow-up care, one did not meet
Criterion A, one completed an earlier version of the study, one found the study too
distressing, and three obtained exclusionary PCL scores between 35 and 43 (these scores
fall outside of either the low/moderate or high symptom groups). One participant
completed part of the study but removed himself due to emotional distress.
The protocol for participants who reported any kind of emotional distress or
desired follow-up care was to escort them to the mental health clinic at the VA hospital,
where they would be referred for a triage visit or a meeting with their mental health or
primary care provider. No veterans requested follow-up care due to emotional distress
from the study. The one participant who discontinued the study declined to seek followup care and reported feeling fine by the time he left the room where he was participating
in the study.
Demographic variables. Ninety participants completed all phases of the study
(77 men, 13 women). The mean age of participants was 58.8 years (SD = 10.6) with the
majority of participants over age 50 (81.1%). Seventy-six participants (83.5%) were
Caucasian, 9 (9.9%) were African-American, 4 (4.4%) were American Indian/Alaskan,
and 1 (1.1%) was Latino.
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Forty-five participants had scores greater than 44 on the PCL and were classified
as having severe symptoms. Forty-five were classified as having low/moderate stress
symptoms (i.e., scores ranging from 17 to 34 on the PCL). These cutoff scores on the
PCL were used in order to increase the chances of obtaining both a signal group (PTSDpositive) and a non-signal group (PTSD-negative) that were of equal size. Participants
who endorsed low/moderate stress symptoms were included because they had
experienced a trauma but would most likely not qualify for a PTSD diagnosis.
Participants from the high severity group were believed to be more likely to receive a
PTSD diagnosis.
Of the participants in the low/moderate group, 41 were men (91.1%) and four
(8.9%) were women. There were 36 (80.0%) men and nine (20.0%) women in the high
severity group. Thus 30.8% of women who participated were in the low/moderate group
and 69.2% were in the high group. Men were far more balanced between severity groups,
with 53.2% in the low/moderate group and 46.7% in the high severity group.
Additional demographic information was collected on all participants who
complted the study. Some information was reported by participants on a demographic
form and some was obtained through the Computerized Patient Record System (CPRS),
the VA database containing patient information. Participants endorsed a range of
religious preferences. The most commonly cited religion or denomination was Roman
Catholic (n = 22; 24.4%), followed by Protestant (n = 19; 21.1%). Seventeen did not
endorse a religious preference (18.8%). The next most common preferences were
Lutheran (n = 11; 12.2%) and Baptist (n = 10; 11.1%).
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History of treatment. Thirteen participants (14.4%) reported that they had
received inpatient psychiatric care in their past, and 59 (65.5%) had received outpatient
care. Of participants endorsing that they had received inpatient care, three were women
and 10 were men. Twelve women (92.3%) endorsed receiving outpatient care, compared
to 47 (52.2%) men who reported receiving outpatient care. Far fewer participants in the
low/moderate severity group reported receiving inpatient care (n = 3) than in the high
severity group (n = 10). Similar findings were obtained when comparing participants
who had received outpatient care (low/moderate: n = 15; high: n = 44).
Participants reported how many psychiatric or mental health therapy sessions they
had attended in the past year. The modal number of sessions attended was zero, which
was endorsed by 41.8% of participants. Half of all participants had attended two or more
sessions in the past year, and over 25% had attended 11 or more sessions. Number of
sessions attended ranged from zero to 273, and there were four participants who had
attended 65 or more sessions in the past year.
Participants also reported which psychotropic medications they had prescriptions
for at the time of the study. Thirty-seven participants did not report any prescriptions, 54
endorsed only one medication, 42 endorsed two or more medications, 21 had
prescriptions for three or more, nine endorsed four or more medications, three endorsed
five or more, and one participant had prescriptions for six psychotropic medications. The
most commonly reported medication was citalopram, which was endorsed by 19
participants (21.1%). The next most frequently reported medications were bupropion (n
= 16; 17.7%) and trazodone (n = 10; 11.1%).
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Service connection status. In the VA population, service connection is
commonly examined, especially as it relates to the diagnosis of PTSD. Aribisi, Murdoch,
Mcnulty, and Fortier (2004) note that veterans achieve service-connected status by
having a documented, compensable condition that was directly caused by or aggravated
by military service. Service connection can result in priority in receiving medical care
through the VA healthcare system, disability payments, and sometimes college payments
for dependents (Aribisi et al., 2004). Table 2 shows the distribution of service connection
percentages. In the present study, just over half of participants (n = 48) received at least
10% total service connection, and 46.2% indicated that they did not receive service
connected status. Only 13 participants (15.4%) received service connection for PTSD.
Slightly more participants received mental health service connection (n = 19).
Table 2
Service Connection Percentages

Service Connection Percentage

a

Service Connection Type

0

10

20

30

40

50

60

70

80

90

100

Totala

42

9

4

3

5

3

4

7

5

2

6

PTSD

77

0

0

5

0

3

0

3

0

0

2

Mental Health

71

0

0

7

0

5

0

4

0

0

3

Cell values reflect numbers of participants
Differences based on sex. Differences between men and women were examined.

Men and women did not differ on frequency of therapeutic contact (i.e., number of
therapy sessions/number of medication consultation sessions attended in the past year)
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(women: M = 18.92, SD = 10.01; men: M = 12.13, SD = 35.52). Men and women did not
differ on total service connection percentage, PTSD service connection, or mental health
service connection.
Significant differences were found between men and women on all of the subscale
means and total severity scores on the CAPS and the CPS –M, with women obtaining
significantly higher scores. These subscale and total severity score means are reported in
Table 3.
Table 3
Comparisons of Men and Women on Subscale and Total Severity Scores

Men

Scale

Women

M

SD

M

SD

t

B

9.12

10.41

21.31

14.81

2.85*

C

15.27

15.46

28.85

18.87

2.46*

D

15.32

11.77

27.69

10.27

3.93***

TSS

39.71

35.82

77.85

42.58

3.05**

B

7.85

8.86

16.69

11.55

2.63*

C

15.04

13.85

28.08

13.70

3.16**

D

14.89

10.27

22.46

9.20

2.69*

TSS

37.78

30.31

67.23

30.20

3.24**

CPS-M

CAPS

Note. *** = p < .001, ** = p < .01, * = p < .05
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Manipulation Check
To determine if the prescreen had the desired effect of creating groups that
differed on CAPS and CPS-M total scores, an initial set of between-groups contrasts was
conducted. Levene’s test for homogeneity of variance revealed significant between
group differences. Consequently, independent samples t-tests using non-pooled
variances were conducted. The degrees of freedom used reflect this adjustment. There
were significant between-group differences for Total Severity on the CAPS, t(74) = -15.6,
p < .001, and on the CPS-M, t(65) = -14.8, p < .001. Participants in the severe
symptomatology group reported higher total severity scores than the low/moderate
severity group on the CPS-M (high: M = 78.0, SD = 26.5; low/moderate: M = 12.4, SD =
13.2) and the CAPS (high: M = 69.2, SD = 19.3; low; M = 14.6, SD = 12.7).
To determine if severity of symptoms was related to variables such as psychiatric
or mental health sessions attended and service connection, between-groups contrasts were
conducted. Levene’s test for homogeneity of variance revealed significant between
group differences. Consequently, independent samples t-tests using non-pooled
variances were conducted. The degrees of freedom used reflect this adjustment.
Between-groups contrasts revealed no significant differences for number of therapy or
medications sessions attended in the past year. Participants in the low/moderate severity
group reported fewer sessions in the past year (M = 5.78, SD = 20.37) than those in the
severe symptomatology group (M = 20.44, SD = 44.96), but this comparison did not
reach conventional levels of significance, t(61) = -1.99, p > .05.
Significant between-groups differences were found for PTSD service connection
percentage, t(44) = -3.73, p < .001, as well as for mental health service connection, t(75)
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= -2.78, p < .01. Participants in the low/moderate group received significantly lower
percentages of PTSD service connection (M = 0.00, SD = 0.00) than those in the severe
symptomatology group (M = 15.78, SD = 28.40). Similarly, significantly lower
percentages were found for mental health service connection when comparing the
low/moderate group (M = 4.44, SD = 18.41) to the severe symptomatology group (M =
18.67, SD = 28.97). Total service connection percentage did not differ significantly
between groups (low/moderate: M = 22.22, SD = 32.47; high: M = 33.78, SD = 36.20).
Item-level descriptive statistics. Table 4 reports means and standard deviations
for each CAPS and CPS-M item. To assess level of skew and kurtosis, the parameter
estimates were divided by the corresponding standard errors. These values appear in
Table 4. Computed values exceeding 1.96 are significant. On the CAPS, all items on
subscale B exceeded the threshold for skewness. Subscale C items C2, C3, C4, and C7
exceeded 1.96. No subscale D items on the CAPS exceeded the threshold for skewness.
All items were positively skewed, indicating a higher distribution of scores at the lower
end of the distribution. Items B1 and B2 on the CAPS exceeded 1.96 for kurtosis.
Subscale C items C1, C3, C4, C5, and C6 exceeded the threshold, and all Subscale D
items values were beyond criterion for kurtosis. All items exceeding threshold for
kurtosis on the CAPS were platykurtotic, except for item C3, which was leptokurtotic.
Measures of skewness and kurtosis indicate that several items on the CAPS are not
normally distributed.
All CPS-M subscale B items were skewed beyond criterion. Items C1, C2, C3,
and C7 exceeded the threshold, and no items from subscale D were skewed beyond
criterion. Like CAPS items, all CPS-M items were positively skewed, indicating a
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clustering of scores at the lower end of the distribution. No CPS-M subscale B items
were kurtotic beyond the threshold. Items C3, C4, C5, and C6 all displayed values above
1.96, and all subscale D items were beyond the threshold for kurtosis. Similar to the
findings on the CAPS, all CPS-M items exceeding criterion for kurtosis were
platykurtotic except for item C3, which was leptokurtotic. Because several CPS-M items
were skewed or kurtotic beyond criterion, normality cannot be assumed for these scores.
Though many items on the CAPS and CPS-M were skewed beyond criterion, the
data were not transformed. By not assuming normality, we employed a conservative
standard, and correlations between items remained high despite skewness.
Transformation would likely yield even higher levels of significance, and because
significance was already achieved, we presented raw data to facilitate ease of
interpretation.
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Table 4
Instrument Comparisons on Item Scores
CAPS

Item

M

SD

B1

2.28

2.52

2.33

B2

2.22

2.53

B3

1.10

B4

CPS-M

skewness kurtosis

M

SD

skewness

kurtosis

rxy

-1.98

2.67

2.60

2.07

-1.69

.81***

2.37

-2.04

2.23

2.40

3.39

-0.56

.87***

2.07

5.99

1.54

1.67

2.67

5.07

0.25

.73***

1.99

2.34

2.52

-1.94

2.17

2.45

3.29

-0.79

.79***

B5

1.59

2.22

4.09

-0.31

2.14

2.59

3.31

-1.18

.77***

C1

2.54

2.68

1.65

-2.68

2.44

2.72

2.68

-1.88

.64***

C2

1.80

2.66

4.29

-0.58

2.33

2.86

3.09

-1.76

.69***

C3

1.11

2.10

6.56

3.05

1.31

2.19

6.29

2.91

.59***

C4

2.84

3.01

1.97

-2.55

2.69

2.91

1.65

-2.86

.69***

C5

3.43

3.08

0.33

-3.22

2.9

3.12

1.86

-2.69

.83***

C6

3.22

3.04

0.71

-3.15

3.33

3.13

1.02

-3.06

.79***

C7

2.05

2.77

3.66

-1.26

2.17

2.75

3.09

-1.75

.75***

D1

4.24

3.08

-1.28

-2.93

4.36

3.22

-1.15

-3.02

.93***

D2

2.60

2.52

1.00

-2.83

3.01

2.71

0.58

-2.82

.70***

D3

3.23

2.82

0.18

-3.17

3.22

2.99

0.49

-3.23

.84***

D4

3.75

2.92

-0.99

-3.04

3.68

3.09

-.13

-3.15

.78***

D5

2.21

2.33

1.94

-2.21

2.84

2.59

1.53

-2.12

.72***

Note. *** = p < .001
Scale-level descriptive statistics. Table 5 reports means and standard deviations
for each CAPS and CPS-M subscale. On the CAPS, subscale B exceeded the customary
1.96 threshold for skewness, while subscales C and D and Total Severity Scores were
within range. Subscales C and D were kurtotic beyond criterion. Total Severity Scores
on the CAPS were also beyond threshold for kurtosis.
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CPS-M subscales B and C were skewed beyond criterion, as were Total Severity
Scores. Subscales C and D on the CPS-M were kurtotic beyond the 1.96 threshold, while
subscale B and Total Severity Scores were within range for kurtosis. Because several
subscales fell outside of range for skewness or kurtosis, normality was not assumed for
subscale means on the CAPS or CPS-M. As stated previously regarding item-level
skewness, data were not transformed. Because all subscales and Total Severity Scores
were significantly correlated, we presented raw data to facilitate ease of interpretation.

Table 5
CAPS-CPS-M Scale Score Comparisons
CAPS
Scale

CPS-M

M

SD

skewness kurtosis

M

B

9.17

9.76

3.44

0.06

10.88 11.86

3.54

-0.57

.93***

C

16.99 14.52

1.38

-2.52

17.23 16.58

2.17

-1.98

.88***

D

16.02 10.43

0.23

-2.28

17.11 12.31

0.14

-2.34

.92***

TSS

42.18 31.92

1.00

-2.40

45.22 39.01

1.98

-1.84

.95***

Note. *** = p < .001
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SD

skewness kurtosis

rxy

Table 6
CAPS and CPS-M Subscale and Total Severity Score Correlations

CAPS

CPS-M

Scale

CAPS

CPS-M

B
1.00

C

B

D

TSS

B

C

D

C

.78

1.00

D

.72

.78

1.00

TSS

.79a

.84a

.79a

1.00

B

.93

.80

.75

.89

1.00

C

.86

.88

.77

.92

.90

1.00

D

.78

.84

.92

.92

.84

.87

1.00

TSS

.89

.88

.85

.95

.91a

.92a

.88a

TSS

1.00

Note.aValues reflect corrected item-total correlations. All values significant at p < .001
level
Reliability: Alpha Coefficients
Clinician-Administered PTSD Scale
Subscale and total alphas. Alpha coefficients for the CAPS subscales were all
above .80. Alphas were .89 for Criterion B, .87 for Criterion C, and .82 for Criterion D.
Removal of any item from subscales B and D resulted in a lower alpha coefficient for that
subscale. A similar pattern of findings emerged for criterion C. However, removal of C3
(inability to recall) resulted in a slight increase in alpha from .87 to .88.

Alpha for the

full scale was .941. Removal of any item from the scale resulted in a lower alpha
coefficient.

1

Alpha was computed at the subscale and item level. When calculated at the subscale level, Chronbach’s
alpha was .89, slightly lower than when computed at the item level. Unless otherwise indicated, throughout
the paper, when Chronbach’s alpha is reported for the entire scale, this refers to the item-level calculation.
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CPS-M
Subscale and total alphas. Alpha coefficients for the CPS-M subscales were all
above .90. Alphas were .96 for Criterion B, .93 for Criterion C, and .90 for Criterion D.
Removal of any item from subscales B, C, and D resulted in lower alpha coefficients.
Alpha for the full scale was .97. Removal of any item from the scale resulted in a lower
alpha coefficient.
Validity Coefficients
To examine the relationship between the CAPS and CPS-M at the item, subscale,
and total score levels, a series of Pearson Product-Moment correlations were conducted.
Item-level correlations. Table 4 reports correlations between CAPS items and
the corresponding CPS-M items. All items were significantly correlated and ranged
from .64 (Item C1: avoidance of thoughts) to .93 (Item D1: difficulty sleeping).
Scale correlations. Correlations between the CAPS subscales and the
corresponding CPS-M subscales are included in Table 5, and the intercorrelations among
all CAPS and CPS-M subscales are reported in Table 6. Subscale scores were
significantly correlated and ranged from .88 (Criterion C) to .93 (Criterion B). Total
Severity Scores on the CAPS and CPS-M were significantly correlated at .95. As
expected, the subscales of the CPS-M were more strongly correlated with the
corresponding CAPS subscale than with other CAPS subscales. These findings are
consistent with the hypothesis that CAPS and CPS-M subscales should be more similar to
each other than to other subscales.
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Convergent validity correlations. Table 7 details the correlations among the
CAPS, the CPS-M, and all convergent validity measures. Specific findings will be
highlighted in the sections that follow.
Purdue PTSD Scale-Revised. The Purdue PTSD Scale-Revised total score mean
was 44.98 (SD = 22.27). All CAPS subscale scores and the total score were significantly
correlated with the Purdue PTSD Total Severity Score: r = .82, .87, .83, and .92 for
Criterion B (reexperiencing), C (avoidance/numbing), D (hyperarousal), and total score,
respectively.
All CPS-M subscale scores and the total score were correlated significantly with
the Purdue PTSD Scale Total Score: r =.87, .91, .90, and .93 for Criterion B
(reexperiencing), C (avoidance/numbing), D (hyperarousal), and total score, respectively.
PTSD Checklist (PCL). The PCL total score mean was 43.54 (SD = 22.68). All
CAPS subscale scores and total score were significantly correlated with the PCL Total
Severity Score: r = .84, .85, .78, and .90 for Criterion B (reexperiencing), C
(avoidance/numbing), D (hyperarousal), and total score, respectively.
All CPS-M subscale scores and the total score correlated significantly with the
PCL Total Severity Score; r = .87, .87, .84, and .90 for Criterion B (reexperiencing), C
(avoidance/numbing), D (hyperarousal), and total score, respectively.
Trauma Related Dissociation Scale (TRDS). The TRDS total score mean was
16.99 (SD = 20.24). All CAPS subscale scores and the total score were significantly
correlated with the TRDS Total Severity Score: r = .66, .68, .64, and .72 for Criterion B
(reexperiencing), C (avoidance/numbing), D (hyperarousal), and total score, respectively.
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All CPS-M subscale scores and the total score correlated significantly with the
TRDS Total Severity Score: r = .77, .78, .75, and .80 for Criterion B (reexperiencing), C
(avoidance/numbing), D (hyperarousal), and total score, respectively.
Beck Depression Inventory (BDI). The BDI total score mean was 18.51 (SD =
14.30). All CAPS subscale scores and the total score were significantly correlated with
the BDI Total Severity Score: r = .72, .82, .77, and .84 for Criterion B (reexperiencing),
C (avoidance/numbing), D (hyperarousal), and total score, respectively.
All CPS-M subscale scores and the total score correlated significantly with the
BDI Total Score: r = .76, .82, .83, and .72 for Criterion B (reexperiencing), C
(avoidance/numbing), D (hyperarousal), and total score, respectively.
Convergent validity findings. Overall, the CAPS was most strongly related to the
other measures of PTSD, less strongly related to the measure of depression, and the least
related to the measure of dissociation. The average correlation between the CAPS
subscales and total score and Purdue PTSD Scale-Revised was .86, followed by an
average correlation with the PTSD Checklist of .84. The average of the CAPS subscales
and total score correlations was lower with the Beck Depression Inventory at .79 and the
lowest with the Trauma Related Dissociation Scale at .67.
The CPS-M showed the same pattern of associations, displaying the highest
correlations with measures of PTSD and lower with those of depression and dissociation.
The average correlation between the CPS-M subscales and total score and Purdue PTSD
Scale-Revised was .90, followed by an average correlation with the PTSD Checklist
of .87. The average of the CPS-M subscales and total score correlations was lower with
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the Beck Depression Inventory and the Trauma Related Dissociation Scale at .78 with
each.
Table 7
CAPS and CPS-M Correlations with Other Measures

Measure

Purdue PTSD
Scale

CAPS Crit B

.82***

Trauma Related
Dissociation
Scale
.66***

Beck Depression
Inventory-II

PTSD
Checklist

.72***

.84***

CAPS Crit C

.87***

.68***

.82***

.85***

CAPS Crit D

.83***

.64***

.77***

.78***

CAPS Total
Severity Score

.92***

.72***

.84***

.90***

CPS-M Crit B

.87***

.77***

.76***

.87***

CPS-M Crit C

.91***

.78***

.82***

.87***

CPS-M Crit D

.90***

.75***

.79***

.84***

CPS-M Total
Severity Score

.93***

.80***

.83***

.90***

Note. *** p < .001
Equivalence Analyses
Scale-level effect sizes. Effect size estimates were made by calculating Cohen’s
d for each subscale and the Total Severity Score ([CPS-M tss – CAPS tss]/pooled SD).
Positive effect sizes imply greater CPS-M mean scale scores. According to Cohen (1992),
when comparing two independent means, effect sizes of .20 or below are small, .21-.50
are medium, and .51-.80 are large. Cohen’s d was .16 for Criterion B, .02 for Criterion
C, .10 for Criterion D, and .09 for the Total Severity Score. These small effect sizes
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indicate that CPS-M mean scale scores were only slightly higher than CAPS mean scale
scores, indicating almost no effect based on the instrument used, or no significant
difference between CAPS and CPS-M mean scores.
Confidence interval analysis. Table 8 provides the data used for the confidence
interval analysis with the CPS-M and CAPS. For the Total Severity Score, the 90%
confidence interval for the CPS-M was -11.87 to 5.79. This corresponds with a lower
confidence limit of -28.14% and an upper confidence limit of 13.73%. These limits are
expressed as percentages of the CAPS mean, which standardizes the confidence intervals.
Because the CPS-M confidence interval is not contained within the ±10% equivalence
interval, the Total Severity Scores on the two instruments are not equivalent. However,
because the 95% confidence interval includes zero (-13.56-7.48), we can conclude that
Total Severity Scores are not statistically different. The Total Severity Score is classified
as ―Not Different and Not Equivalent.‖
For Criterion B, the 90% confidence interval for the CPS-M was -4.40 to 0.98
(-47.98% - 10.69%). Because the CPS-M confidence interval is not contained within the
CAPS equivalence interval of ±10%, Criterion B on the two instruments is not equivalent.
Because the 95% confidence interval includes zero (-4.92-1.49), we can conclude that
Criterion B scores are not statistically different. Criterion B is classified as ―Not
Different and Not Equivalent.‖
For Criterion C, the 90% confidence interval for the CPS-M was -4.09 to 3.62
(-24.13% - 21.30%). Because the CPS-M confidence interval is not contained within the
10% equivalence interval, Criterion C on the two instruments is not equivalent. Because
the 95% confidence interval includes zero (-4.84-4.36), we can conclude that Criterion C
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scores are not statistically different. Criterion C is classified as ―Not Different and Not
Equivalent.‖ For Criterion D, the 90% confidence interval for the CPS-M was -3.92 to
1.74 (-24.44% - 10.84%). Because the CPS-M confidence interval is not contained
within the CAPS equivalence interval of ±10%, Criterion D on the two instruments is not
equivalent. Because the 95% confidence interval includes zero (-4.46-2.28), we can
conclude that Criterion D scores are not statistically different. Criterion D is classified as
―Not Different and Not Equivalent.‖
Because there has been little research on using confidence interval analysis with
psychological assessment instruments, we theorized that the ± 10% equivalence interval
recommended by Rogers et al. (1993) may be too stringent. When we expanded this to a
± 20% equivalence interval, we found similar results. All subscales were classified as
―Not Different and Not Equivalent.‖ Therefore, we are basing our conclusions on the
classifications found using the ± 10% equivalence interval. Figure 6 visually displays
results from Table 8 for easier interpretation.
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Table 8
Confidence Interval Analysis Statistics
Subscales
Total
Severity
Score

Criterion
B

Criterion
C

Criterion
D

CAPS Mean

42.18

9.17

16.99

16.02

10 % Equivalency
Interval

±4.22

±0.92

±1.70

±1.60

20% Equivalency
Interval

±8.44

±1.84

±3.40

±3.20

90% CI

-11.87-5.79

-4.40-0.98

-4.09-3.62

-3.92-1.74

95% CI

-13.56-7.48

-4.92-1.49

-4.84-4.36

-4.46-2.28

Upper Confidence
Limit (UCL) as %
of CAPS Mean

13.73%

10.69%

21.30%

10.84%

Lower Confidence
Limit (LCL) as %
of CAPS Mean

-28.14%

-47.98%

-24.13%

-24.44%

CPS-M 90% CI
Within CAPS 10%
Equiv. Range?

No

No

No

No

CPS-M 90% CI
Within CAPS 20%
Equiv. Range?

No

No

No

No

CAPS Mean Within
CPS-M 95% CI?

Yes

Yes

Yes

Yes

Classification per
Rogers, Howard, &
Vessey (1993)

Not
Different,
Not
Equivalent

CAPS

CPS-M

Not
Not
Not
Different, Different, Different,
Not
Not
Not
Equivalent Equivalent Equivalent
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Figure 6. Confidence interval analysis.
A final complication relates to the formula used to compute the confidence
interval. In the standard equation, which is used in the pharmaceutical industry, the
assumption is that a between-groups standard error should be computed. However, in the
current investigation, participants were administered both the CPS-M and the CAPS.
Consequently, use of a within-groups standard error in the computation of the confidence
may result in these measures being judged equivalent. To test this notion, confidence
intervals for Total Severity Scores using the within-groups standard error were calculated.
Table 9 shows these results. This resulted in Total Severity Scores being classified as
―Statistically Different and Not Equivalent.‖ When the range was expanded to the ± 20%
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equivalence interval, the classification changed to ―Statistically Different and
Equivalent.‖
Table 9
Confidence Interval Analysis Statistics Using Adjusted Standard Error

Total Severity Score
CAPS
CAPS Mean

42.18

10 % Equivalency Interval

±4.22

20% Equivalency Interval

±8.44

CPS-M
90% CI

-5.31- -0.78

95% CI

-5.74- -0.34

Upper Confidence Limit
(UCL) as % of CAPS Mean

-1.84%

Lower Confidence Limit
(LCL) as % of CAPS Mean

-12.58%

CPS-M 90% CI Within CAPS
10% Equiv. Range?

No

CPS-M 90% CI Within CAPS
20% Equiv. Range?

Yes

CAPS Mean Within CPS-M
95% CI?

No

Classification

Statistically Different, Not Equivalent

The mean difference between CAPS and CPS-M Total Severity Scores was -3.18
(SD = 12.85). Almost half of the CPS-M Total Severity Scores fell within ± 5 points of
CAPS scores (49.2%), and 70.9% fell within ± 10 points of CAPS Total Severity Scores.
The distribution of difference scores was not skewed or kurtotic beyond the 1.96 criterion
(skewness: -1.065, SE = .258; kurtosis: 1.605, SE = .511), suggesting a normal
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distribution. Modal score differences of 0 and -2 were found between the two
instruments. See Figure 7 for distribution of differences between the paired CAPS and
CPS-M Total Severity Scores.

Figure 7. Distribution of CAPS-CPS-M Total Severity Score differences.
Signal Detection Statistics
Kappa coefficients. The CPS-M and CAPS were scored using the 1-2 symptom
presence rule (i.e., score of 1 or higher on frequency and score of 2 or higher on intensity
for an individual item), the 2-2 symptom presence rule (i.e., scores of 2 or higher on both
frequency and intensity for individual items), the Sum 4 symptom presence rule (i.e., sum
of 4 of higher when adding frequency and intensity scores on an individual item), and the
Total 65 rule (i.e., total severity scores of 65 or higher on the scale).
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The 1-2 symptom presence scoring rule resulted in 35 positive cases and 55
negative cases on the CAPS and 39 positive and 51 negative cases on the CPS-M. The 22 symptom presence scoring rule resulted in 29 positive and 61 negative cases on the
CAPS and 35 positive and 55 negative cases on the CPS-M. The Sum 4 symptom
presence scoring rule resulted in 31 positive and 59 negative cases on the CAPS and 36
positive and 54 negative cases on the CPS-M. The Total 65 scoring rule resulted in 29
positive and 58 negative cases on the CAPS and 29 positive and 61 negative cases on the
CPS-M. Because three participants did not meet criterion A after beginning the CAPS
interview, they were considered negative for PTSD diagnosis, but Total Severity scores
were not obtained. Thus, the n for CAPS Total 65 scoring rule calculations was 87
instead of 90 as with the other scoring rules, which were based on presence or absence of
individual symptoms.
When using the same symptom presence rule on both instruments, the Total 65
rule produced the lowest kappa (.71), and the Sum 4 rule produced the highest kappa
(.79). According to Altman (1991), kappa scores that fall within the range of .61 to .80
show good agreement. There was good agreement across all scoring rules, indicating that
the CPS-M agreed with the CAPS well regardless of scoring rule used. See Table 10 for
kappa coefficients. The 1-2 symptom presence rule was used for signal detection
analyses because positive and negative cases were most closely balanced when using this
rule to determine PTSD diagnosis on the CAPS. Diagnostic agreement between the
CAPS and CPS-M based on this rule was also good, with a kappa coefficient of .77.
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Table 10
CAPS-CPS-M Diagnostic Agreement: Kappa Coefficients

CPS-M symptom presence scoring rule
CAPS symptom
presence scoring rule

1-2 Rule

2-2 Rule

Sum 4 Rule

Total 65 Rule

1-2 Rule

.77

.77

.79

.66

2-2 Rule

.72

.76

.79

.75

Sum 4 Rule

.72

.76

.79

.70

Total 65 Rule

.74

.68

.71

.71

CPS-M ROC curve analysis. Receiver Operator Characteristics (ROC) curves
were conducted to find the optimal cut point on the CPS-M that would maximize
diagnostic sensitivity and specificity on the CAPS. Signal detection analyses were
conducted using the MedCalc v11.1.1 statistical program. The CAPS 1-2 symptom
presence scoring rule, in which participants must receive at least a rating of 1 or higher
on symptom frequency and a 2 or higher on intensity, resulted in 35 participants who
were positive for PTSD diagnosis and 55 who were negative. The area under the ROC
curve was .95 (p < .001), which, according to Swets (1988), is considered high diagnostic
accuracy. A cut score of 40 produced 100.0% sensitivity and 83.6% specificity. Figure 8
shows the receiver operating characteristic (ROC) curve with sensitivity plotted against
false alarm rate. The optimal cut score is located on the graph at the data point closest to
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the upper left corner. This cut point was selected since it represents the point in the ROC
distribution that best balances sensitivity in detection against false alarms (or, 1specificity).
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Figure 8. CPS-M ROC curve based on CAPS 1-2 symptom presence scoring rule.
Figure 9 shows the ROC curve for the CPS-M based on the CAPS 2-2 symptom
presence scoring rule, in which participants must receive a rating of 2 or higher on both
frequency and intensity. The CAPS 2-2 rule resulted in 29 participants who were
positive for PTSD diagnosis and 61 who were negative. The area under the ROC curve
was .96 (p < .001), which, according to Swets (1988), is considered high accuracy. A cut
score of 59 produced 93.1% sensitivity and 90.2% specificity.
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Figure 9. CPS-M ROC curve based on CAPS 2-2 symptom presence scoring rule.
The CAPS Sum 4 rule, in which a symptom is considered present when frequency
plus intensity scores equal 4 or higher, resulted in 31 participants who were positive for
PTSD diagnosis and 59 who were negative. The area under the ROC curve was .94 (p
< .001), which is considered high accuracy. A cut score of 50 produced 96.8% sensitivity
and 83.1% specificity. Figure 10 shows the ROC curve for the CPS-M based on the
CAPS Sum 4 symptom presence scoring rule.
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Figure 10. CPS-M ROC curve based on CAPS Sum 4 symptom presence scoring rule.
Figure 11 shows the ROC curve for the CPS-M based on the CAPS Total 65
scoring rule, in which participants are positive for PTSD diagnosis when they receive a
total severity score of 65 or higher. The CAPS Total 65 rule resulted in 29 participants
who were positive for PTSD diagnosis and 58 who were negative. The area under the
ROC curve was .96 (p < .001), which is considered high diagnostic accuracy. A cut score
of 50 produced 100.0% sensitivity and 82.8% specificity.
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Figure 11. CPS-M ROC curve based on CAPS Total 65 scoring rule.
Figure 12 provides a distribution of CPS-M scores based on the CAPS 1-2
symptom presence scoring rule. The horizontal line on the graph represents the CPS-M
Total Severity Score cut point of 40 that produced the best sensitivity and specificity.
Points above the line represent participants classified as PTSD-positive on the CPS-M,
while points below the line represent PTSD-negative cases. Points plotted in the column
labeled ―1‖ indicate PTSD-positive classifications on the CAPS, whereas the ―0‖ column
indicates PTSD-negative cases. This graph reproduces the 2 x 2 signal detection
contingency table where points in the upper right quadrant and lower left quadrant are
correct classifications and points in the upper left and lower right quadrants are
misclassifications. Comparing the CPS-M to the CAPS using the 1-2 scoring rule with a
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cut score of 40 resulted in 100% sensitivity and 83.6% specificity. There were zero false
negatives and nine false positives.
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Figure 12. Distribution of CPS-M Scores based on CAPS 1-2 scoring rule.
Figure 13 provides a distribution of CPS-M scores based on the CAPS 2-2
symptom presence scoring rule. A cut score of 59 resulted in 93.1% sensitivity and
90.2% specificity. Two false negatives resulted, and six false positives were found.
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Figure 13. Distribution of CPS-M Scores based on CAPS 2-2 scoring rule.
Figure 14 provides a distribution of CPS-M scores based on the CAPS sum 4
scoring rule. A cut score of 50 resulted in 96.8% sensitivity and 83.1% specificity. One
false negative resulted, and ten false positives were found.
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Figure 14. Distribution of CPS-M Scores based on CAPS Sum 4 scoring rule.
Figure 15 provides a distribution of CPS-M scores based on the CAPS total 65
scoring rule. A cut score of 50 resulted in 100% sensitivity and 82.8% specificity. There
were zero false negatives and ten false positives found.
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Figure 15. Distribution of CPS-M Scores based on CAPS Total 65 scoring rule.
When analyzing signal detection statistics, it is important to consider the costs of
false positives or negatives. In some situations, the cost of a false negative (i.e., missing
a diagnosis of cancer) would be far higher than that of a false positive, or false alarm (i.e.,
incorrectly diagnosing cancer that is not present). This is an important factor in
determining a cut point score. Varying the cut point changes the sensitivity and
specificity, so the research can determine how best to balance false positives and
negatives. In the diagnosis of PTSD, it would seem that finding a cut point that
minimizes false negatives (i.e., not diagnosis PTSD when it is present) would be
responsible. As such, the cut score of 40 when using the CAPS 1-2 scoring rule seems to
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have clinical relevance, as it produces high sensitivity and specificity, with zero false
negatives.
CPS-M signal detection compared to other instruments. The final phase of the
analysis involved comparing the ROC curves of the CPS-M, PTSD Checklist, Purdue
PTSD Scale, Beck Depression Inventory, and the Trauma-Related Dissociation Scale.
We hypothesized that the ROC curve for the CPS-M would obtain an AUC estimate that
was either not significantly different than those of the convergent validity measures or
accounted for slightly more area than the AUCs for the convergent validity measures.
Total scores for all five instruments were compared, resulting in AUCs of .94 (SE
= .02, CI = 0.86 to 0.98) for the PCL, .92 (SE = .03, CI = 0.85 to 0.97) for the Purdue, .94
(SE = .02, CI = 0.87 to 0.98) for the BDI, .91 (SE = .03, CI = 0.83 to 0.96) for the TRDS,
and scores ranging from .94 to .96 for the CPS-M, based on the different scoring rules.
Figures 16, 17, 18, and 19 show the ROC curves for each of the five measures based on
the four scoring rules (i.e., 1-2, 2-2, Sum 4, and Total 65). The AUC for the CPS-M was
highest when using the 2-2 and Total 65 symptom presence scoring rules (.96) and lowest
when using the Sum 4 rule (.94).
There were no significant differences between the CPS-M and the PTSD
Checklist based on any scoring rules. Significant differences were found between AUCs
when comparing the CPS-M to the TRDS based on all CAPS scoring rules except the 1-2
rule. Between the TRDS and CPS-M, differences between areas under the curves were
0.06 (SE = .03, 95% CI = 0.00 to 0.11, p < .05) using the CAPS 2-2 rule, 0.06 (SE = .02,
95% CI = 0.00 to 0.10, p < .01) using the CAPS Sum 4 rule, and 0.09 (SE = .03, 95% CI
= 0.03 to 0.15, p < .05) using the CAPS Total 65 rule. These significant differences
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suggest that the CPS-M is more efficient at diagnosing PTSD than the TRDS, which was
hypothesized. The AUC for the CPS-M was also significantly higher than those of the
Purdue and BDI when using the CAPS Sum 4 rule. The difference between the areas
under the curve using the CAPS Sum 4 rule were .04 (SE = .02, 95% CI = 0.01 to 0.08, p
< .05) between the Purdue and CPS-M and .06 (SE = .03, 95% CI = 0.01 to 0.11, p < .05)
between the BDI and CPS-M. These differences suggest that the CPS-M was slightly
more efficient at diagnosing PTSD based on the Sum 4 rule. When using any other rule,
AUCs were not significantly different between the CPS-M and other measures,
suggesting they were similarly efficient in their ability to detect PTSD.
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Figure 16. ROC curves for the PCL, Purdue, BDI, TRDS, and CPS-M (based on CAPS
1-2 scoring rule).
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Figure 17. ROC curves for the PCL, Purdue, BDI, TRDS, and CPS-M (based on CAPS
2-2 scoring rule).
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Figure 18. ROC curves for the PCL, Purdue, BDI, TRDS, and CPS-M (based on CAPS
Sum 4 scoring rule).
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Figure 19. ROC curves for the PCL, Purdue, BDI, TRDS, and CPS-M (based on CAPS
Total 65 scoring rule).
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Discussion
This study compared the CPS-M to the CAPS in order to test the convergent and
discriminant validity of the former and to examine its diagnostic efficiency with regard to
PTSD diagnosis. All items and subscales were significantly correlated, which is not
surprising given that the CPS-M was modeled after the CAPS. Total severity scores on
the CAPS and CPS-M were most strongly correlated, followed by subscale B
(reexperiencing), D (hyperarousal), and C (avoidance/numbing). As predicted, subscales
on the CPS-M were better correlated with their corresponding subscale on the CAPS than
with others. As hypothesized, the CPS-M was most strongly correlated with the CAPS,
moderately correlated with other measures of PTSD, and lowest with measures outside of
PTSD (i.e., measures of depression and dissociation). This pattern of correlations
supports the construct validity of the CPS-M.
Total severity scores on the CPS-M were slightly higher than those on the CAPS,
though this difference was not significant. Difference scores were normally distributed,
though several outliers were present. It is hypothesized that the few outliers in difference
scores can be accounted for by veteran confusion about trauma reporting. A few veterans
began responding on either the CAPS or CPS-M based on a different trauma than that
they had discussed in other portions of study and were reminded to respond based on the
same trauma. However, it is possible that several veterans continued responding based
on a different trauma, which could result in difference between CAPS and CPS-M
severity.
The CPS-M demonstrated good internal consistency, with alpha coefficients for
the subscales all above .90 and a full scale alpha of .97. These values compared
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favorably with the CAPS, with subscale alphas above .80 and a full scale alpha of .94.
Criterion D on the CPS-M yielded the lowest value for coefficient alpha. This was also
true of the CAPS. This somewhat lower alpha value for Criterion D across both was
most likely due to a variety of factors. First, the sample included veterans, many of
whom tend to have irregular sleep patterns frequently caused by variables not related to
trauma. Many respondents indicated during the CAPS interview that they had
encountered sleep problems but were not sure if these were related to their trauma so
much as other medical issues. Second, many respondents reported difficulties hearing.
Several stated during the interview that they were often startled when someone entered a
room because they ―could not hear them coming.‖ These respondents expressed that the
startle response had more to do with their hearing loss than with trauma. Conceptually,
these findings suggest that the CAPS and the CPS-M may both yield false positives for
this symptom category. These data also suggest that a possible failing of the CAPS was
recreated in the CPS-M. Unfortunately, the absence of a ―true‖ gold standard prevents a
careful examination of the diagnostic utility of the CAPS.
Confidence interval testing revealed that, although the CPS-M scales were not
statistically different from the corresponding CAPS scales, none of the CAPS and CPS-M
scales were equivalent. These findings provide partial support for the hypothesized
equivalence. Confidence interval analysis is a method that has still not been used much
in the field of psychological diagnosis. As it has been used in medicine, stringent
equivalence intervals have been employed. It is possible that the equivalence intervals
used in the current study were too stringent. This notion was tested by using a broader
equivalence interval of ±20%. However, even when the equivalence interval was
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expanded, the findings indicate that the CPS-M and the CAPS are not equivalent. It is
possible that this may still be too stringent for determining equivalence of two
psychological assessment instruments.
Another possibility is that the tests were not equivalent due to factors inherent in
our sample. Many of the participants were older adults (M = 58.8; SD = 10.6) who
expressed great discomfort with computer use. Several reported confusion and anxiety
when completing the CPS-M. These feelings could have led to carelessness in choosing
responses as well as attempts to quickly finish, resulting in responses that were more
reflective of their mood at the time than of their symptoms related to the trauma. This
could have also contributed to the slightly higher mean for CPS-M total severity scores,
although this difference was not significant.
This reported anxiety is inconsistent with findings from several studies in which
users preferred computerized assessment over face-to-face or paper-and-pencil measures.
However, the samples in these studies were very different from the current study in both
age and familiarity with computers, including college students (Vispoel, 2000; Vispoel,
Boo, & Bleiler, 2001), retail managers with a mean age of 42 years (Richman-Hirsh,
Olson-Buchanan, and Drasgow, 2000), and psychiatric inpatients with a mean age of 43.5
years (Weber et al., 2003). Weber et al. found that participants who were older or less
educated reported more difficulty with the computerized assessment than did younger or
more educated participants.
In two previous phases of the current study, the Computer Anxiety Rating Scale
(CARS: Miller & Rainer, 1995) was administered to participants to determine their level
of computer-related anxiety. On the CARS, participants rate the level of computer-
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related anxiety on a seven-point Likert-type scale anchored by 1 (less anxious) and 7
(most anxious). CARS scores can a range from 7 to 35. Mason (2005) reported a CARS
mean total score of 13.74 (SD = 5.02), suggesting negligible levels of computer-related
anxiety in a sample of college students endorsing a trauma history. In a clinical sample
of 161 participants from two sites, a VA outpatient clinic (n = 56) and a large urban
outpatient clinic (n = 105), Mason (2007) reported a CARS total score mean of 15.04 (SD
= 6.35), suggesting that aggregate levels of computer-related anxiety were relatively low.
The mean age of participants (M = 50.12) in the Mason (2007) study was lower than that
in the current study (M = 58.8), which may contribute to the disparity in reported
computer anxiety.
A final consideration was that the tests may not have been equivalent due to the
equivalence methodology used. Because there is no standard for calculating confidence
intervals in psychological assessment, the methodology detailed by Rogers et al. (1993),
which assumes a between-groups design, was followed closely. Because equivalence
testing has been mainly used in pharmaceutical research, there is no guideline for withingroups designs.
Next the diagnostic utility of the CPS-M was examined. There was good
agreement between the CPS-M and the CAPS across all scoring rules. The 1-2 symptom
presence rule was used for signal detection analyses because positive and negative cases
were most closely balanced when using this rule to determine PTSD diagnosis on the
CAPS. As hypothesized, signal detection statistics revealed high accuracy of the CPS-M
in diagnosing PTSD and an AUC of .95. A cut score of 40 produced 100.0% sensitivity
and 83.6% specificity. This is considered high diagnostic accuracy, which improves
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upon the medium accuracy reported in the Mainka (2005) study, in which a cut score of
45 using the CAPS 1-2 symptom presence scoring rule yielded overall diagnostic
efficiency of .78, sensitivity of .63 and specificity of .80.
These diagnostic efficiency statistics compared favorably to previous signal
detection studies comparing PTSD instruments to the CAPS. The CPS-M’s overall
diagnostic efficiency of .95 was higher than any studies detailed in our review of the
literature, with the next highest reported overall efficiency being .94, which resulted
in .97 sensitivity of specificity of .87 on the PTSD Checklist (Ventureyra et al., 2002).
No other studies reported 1.00 sensitivity, and the next highest reported sensitivity
was .98 on the PTSD Checklist (Forbes et al., 2001). The CPS-M specificity score of .84
was higher than that reported in most reviewed studies, though higher scores were
reported for the PTSD Checklist (.97; Hudson et al., 2001) and the Korean version of the
Short PTSD Rating Interview (.93; Kim et al., 2008). The same specificity was reported
for the PTSD Checklist - Civilian version (Bollinger et al., 2008) and Breslau’s 7-item
PTSD screen (Kimerling, Ouimette et al., 2006).
These findings are encouraging with regard to the ability of the CPS-M to
accurately diagnose PTSD. Though we focused on the diagnostic efficiency based on the
CAPS 1-2 symptom presence scoring rule, the diagnostic efficiency statistics produced
by the other scoring rules also favorably compared to previous single detection studies,
with overall diagnostic efficiencies on the CPS-M ranging from .94-.96, sensitivity scores
ranging from .93-1.00, and specificity scores ranging from .83-.90. Because the CPS-M
was directly modeled after the CAPS, we would expect that its diagnostic efficiency
relative to the criterion would be higher than that found for other PTSD instruments.
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Though some of these instruments are similar to the CAPS, the CPS-M asks the same
questions and provides the same prompts as a computerized adaptation of the parent
instrument.
A limitation inherent in signal detection work is that cut scores are very samplespecific. Cut scores vary widely across studies on the same instrument due to factors
such as sample age, trauma history, and history of treatment. This makes it difficult to
examine the clinical utility of the cut score provided. It is therefore necessary to be
cautious when generalizing a specific cut score outside of the studied population.
Clinicians are encouraged to examine research in which the sample studied closely
resembles their patient population. Additionally, this calls for more research in large
samples with heterogeneous variables (i.e.-wider age range, several study sites).
In the final phase of analysis, the ROC curve of the CPS-M was compared to
ROC curves produced by the Purdue PTSD Scale, PTSD Checklist, BDI, and TRDS. It
was hypothesized that the ROC curve produced by the CPS-M would be slightly better or
would not be significantly different from those produced by these other instruments. This
hypothesis was supported by the finding that there were not significant differences
between the CPS-M and the PCL using any scoring rule, the CPS-M was as efficient as
the Purdue and BDI on all but one scoring rule, and the CPS-M was more efficient than
the TRDS using all but one rule. As expected, the CPS-M was better at diagnosing PTSD
than the TRDS, which is a measure of dissociation. It was as efficient as the other two
measures of PTSD, the Purdue and the PCL.
The CPS-M was not more efficient at diagnosing PTSD than the BDI, a measure
of depression. One possible reason for the lack of significant difference in efficiency
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between these two instruments is the high comorbidity between depression and PTSD,
especially in veterans. When reviewing the literature, Chan, Cheadle, Reiber, Unutzer,
and Chaney (2009) reported that, among veterans with a PTSD diagnosis, rates of
comorbid depression ranged from 29% to 68%. Among veterans with major depression
diagnoses, rates of comorbid PTSD ranged from 36% to 51% (Chan et al., 2009). As
many of the study participants were patients recruited from the mental health clinic, it is
likely that many had diagnoses of major depression and/or PTSD.
A surprising finding was that only 13 participants had service-connected status for
PTSD, when the number of participants classified as PTSD-positive based on CAPS
diagnosis ranged from 29 to 35 across scoring rules. This may have occurred for several
reasons. First, at the time of the study, the wait time for a PTSD evaluation to determine
service connection ranged from two to four months. It is possible that many veterans
were waiting to be evaluated, though we do not have data on how many actually applied
for service connection. However, given the age of the participants (M = 58.8, SD = 10.6),
this explanation is somewhat less likely.
Second, many of the participants were recruited from primary care and had not
had any connection with the mental health or PTSD clinics. While many veterans enjoy
close interpersonal connections, several studies have documented increased feelings of
alienation and isolation among combat veterans with PTSD (Egendorf, Laufer, & Sloane,
1981; Rippy, 2008). As many veterans receive information from each other (e.g., how to
obtain service connected status, treatment options, outreach resources), it is possible that
limited interpersonal connection has precluded some veterans from obtaining information
about the treatment or service connection options available to them.
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Third, several participants noted that they did not want any kind of assistance
from the government for their PTSD, indicating the desire to ―handle it.‖ There is a long
history of veteran disenfranchisement from the VA Medical Center. The Veterans
Healthcare Amendment Act of 1979 (PL-96-22), also known as Operation Outreach, was
developed to provide comprehensive psychosocial services to Vietnam-era veterans.
This resulted in the development of veteran outreach centers across the nation, often
housed in storefronts and other nongovernmental buildings and staffed by Vietnam
veterans (Blank, 1982). Giles (1981) estimated that these centers delivered services to
about 20 to 50 percent of Vietnam veterans suffering from PTSD symptoms.
In 1983, Congress passed Public Law 98-160, mandating a study of readjustment
and mental health status of Vietnam veterans, which became known as the National
Vietnam Veterans Readjustment Study (NVVRS; Kulka et al., 1990). One of the goals of
this study was that veterans would become connected with other veterans and would
more readily seek services. While many veterans have taken advantage of these
connections, responses from participants in the present study indicate that some
individuals still prefer to keep private their symptoms and need for assistance.
Finally, the possibility exists that participants, though assured that the study had
nothing to do with their diagnoses, benefits, or service connection, still hoped that the
results of the study would be reported to the VA. It is possible that some of these
individuals had been evaluated and determined to not meet criteria for PTSD service
connection. This hypothesis is reinforced by several participants who asked at the
completion of the study how they had performed or when the results would be shared
with their provider.
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Conclusions
The current study had a number of limitations. First, the demographic
compilation of our sample somewhat limits the generalizability of our findings.
Participants were mostly men (77 men, 13 women) who were over the age of 50 (81.1%),
which is representative of the VA population. The cut score and resulting diagnostic
efficiency are strongly supported in older adult males with a wide range of traumas.
Future research should include a clinical sample from several sites with a younger age
range, as well as more equal representation of men and women. Additionally, the
majority of the participants were Caucasian (83.5%), which was representative of the
Ann Arbor VA population, but this limits the generalizability of findings to other racial
groups.
A second limitation of the study is the high rate of comorbidity in veterans,
especially those suffering from depression or PTSD. While the current study did not
assess comorbidity, rates of comorbid depression range from 29% to 68% for veterans
with a primary PTSD diagnosis and from 36% to 51% for veterans with a primary major
depressive diagnosis (Chan et al., 2009). Because participants were not asked to report
diagnoses, the current study was unable to examine the diagnostic efficiency of the CPSM based on presence or absence of depression. In examining BDI-II scores, we found
that over half of veterans reported at least mild depression (scores of 14 or higher),
though these scores were not converted into diagnoses. While the comorbidity likely
inherent in the sample is representative of much of the PTSD population, future
validation of the CPS-M should also focus on individuals without comorbid diagnoses or
should assess for comorbidity at the time of the study.
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Overall, findings were encouraging regarding the CPS-M. It displayed good
internal consistency at both the full scale and subscale levels. It was significantly
correlated with the CAPS and was also more strongly associated with other measures of
PTSD than with the measures of depression and dissociation. This lends support to its
use for the diagnosis of PTSD.
Confidence interval analysis revealed that, though not statistically different, the
CPS-M and CAPS were not equivalent, which did not support the original prediction. It
was theorized that reasons for this include the potential that the equivalence intervals
used were too stringent for psychological diagnosis or that respondents’ discomfort and
anxiety with using a computer could have led to slightly elevated responses on the CPSM that were more reflective of their mood than of their symptomatology.
Signal detection statistics were excellent for the CPS-M and compared favorably
to other studies using the CAPS as the criterion. The overall diagnostic efficiency and
sensitivity obtained were higher than those reported in all other reviewed studies, and the
CPS-M specificity score was higher than that reported in all but two other studies.
Regardless of the scoring rule used, the diagnostic efficiency statistics revealed high
diagnostic accuracy of the CPS-M relative to the CAPS.
ROC curve analysis revealed that the CPS-M was more efficient at PTSD
diagnosis than the measure of trauma, and as efficient at the measures of PTSD and
depression. While this matched the initial hypothesis, it was suggested that future
research that separates participants by comorbid diagnoses would yield a ROC curve that
is better than that for the measure of depression.
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The CPS-M is a computerized adaptation of the CAPS that addresses several of
the limitations of the CAPS. According to Weathers et al. (2001), limitations of the
CAPS include its lengthy administration time, cumbersome training, overlap of the
frequency and intensity prompts, and the hesitation of individuals to disclose sensitive
information immediately upon meeting the administrator or clinician. With regard to
administration time, average CPS-M completion time in the present study was 30 minutes,
compared to average administration time of an hour and a half for the CAPS, making it
far more efficient. This provides support for the CPS-M as an excellent assessment
instrument for use in the field or in cases in which individuals are not able to sit through a
lengthy interview.
The second limitation of the CAPS is also addressed by the CPS-M. The only
training required for the CPS-M is a practice administration so the examiner is familiar
with the way the program runs. Interviewers are not required to assist with or even be
present during the administration. The complaint of overlap of the frequency and
intensity prompts is not entirely addressed in the CPS-M, though the program is
structured differently, so that this may seem less redundant. Participants first endorse
presence or absence of each symptom. The program then cycles through only the
symptoms they endorsed and assesses frequency, and a final round assesses intensity.
The final criticism of the CAPS is that it often requires individuals to disclose
sensitive information to an examiner immediately upon meeting that person. This is the
case with all interview-based assessment, and the CPS-M sidesteps this criticism by
allowing individuals to report their trauma and endorse symptoms privately. Turner, Ku,
Rogers, Lindberg, Pleck, and Sonenstein (1998) suggested that computerized interviews

96

encourage the disclosure of more sensitive information than face-to-face interviews.
According to Mason (2007), this is particularly advantageous in the assessment of
traumas that are difficult or embarrassing to discuss, such as unwanted sexual
experiences or death caused to another person (i.e., killing another soldier in combat). A
disadvantage of this approach is that individuals are not provided with any type of
empathy or understanding that an examiner may show during the interview. While some
respondents may feel more comfortable reporting traumatic events to a computer rather
than a person, there are certainly some who would prefer human contact and interaction.
Because the CPS-M is modeled after the CAPS and DSM-IV-TR diagnostic
criteria, changes in diagnostic criteria will necessitate changes in the CPS-M, which
presents a limitation of this instrument. However, the CPS-M addresses many of the
limitations of the CAPS and provides an excellent alternative for PTSD assessment
remotely and without the presence of clinicians. Based on its high associations with the
screening measures in this study, the Purdue and PCL, arguments can be made for its use
as a remote screening instrument.
It also shows promise as a diagnostically accurate instrument that can be used in
VA medical centers, which typically have long wait times for PTSD evaluations. The
reduction in administration time and removal of the need for a clinician allow it to be
used more quickly, more often, and with more patients. These advantages also lend
support to its use in settings such as domestic violence shelters, college counseling
centers, and emergency rooms. Comparison of the CPS-M to the gold standard CAPS
and other PTSD measures lead to the conclusion that the CPS-M is an excellent
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diagnostic tool that not only sidesteps many of the limitations of the CAPS but fits well
into the emerging world of computerized assessment.
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APPENDIX A: Screening Packet Cover Page

The purpose of this research is to examine the properties of a computerized interview for
posttraumatic stress disorder (PTSD). Posttraumatic stress symptoms sometimes occur after
individuals have been exposed to an especially stressful event. The purpose of this screening
packet is to identify potential research participants for our study. Please complete the
information below and the attached questionnaires. The demographic information will not
influence your participation in the study and will be detached from your responses.
In you qualify for participation in the study, one of our lab research assistants will call you and
set up an appointment time for you to come into the clinic or hospital. At that point, you will
complete the computerized interview and a face-to-face interview conducted by one of the
research staff. The expected total participation time for all aspects of the research is between 6090 minutes.
Any participant who completes the entire study will receive a $10 gift card to a local retail store.
Your participation or responses will not in any way impact your diagnosis or compensation for
psychological or psychiatric treatment at this time or in the future.
Thank you for your assistance!
Your First Name
Your Last Name
Your Home Phone Number
(for appointment scheduling purposes)
Your Cell Phone Number
(for appointment scheduling purposes)
Best way to reach you. May we leave a message
at this number?
Best times to call you to set up an appointment?
Best appointment times for you?
(we will work around your schedule)
To keep your information confidential, this page will be detached from the rest of your
screening data after scores on the screening instruments or participation is complete.
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Appendix B: Risk of Harm Assessment
Risk of Harm Assessment
1) ―In the past week have you had thoughts about harming yourself?” Yes
If No Skip to #2

No

―Can you tell me today that you will not harm yourself?‖

No

Yes

If no, then the veteran is not eligible for the study and should be connected with a triage
clinician (Dr. Rauch or scheduled provider) immediately for follow-up of suicidal risk.
If Yes, let the veteran know that should he/she feel that they are a risk to harm themselves,
they should either come immediately to urgent care at the VA, dial 911, or go to the
nearest emergency room.
2) ―In the past week have you had thoughts about harming others?” Yes
If No Skip to #2

No

―Can you tell me today that you will not harm others?‖

No

Yes

If no, then the veteran is not eligible for the study and should be connected with a triage
clinician (Dr. Rauch or scheduled provider) immediately for follow-up of risk to harm
others.
If Yes, let the veteran know that should he/she feel that they are a risk to harm others,
they should either come immediately to urgent care at eth VA, dial 911, or go to the
nearest emergency room.
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APPENDIX C: Life Events Checklist
Listed below are a number of difficult or stressful things that sometimes happen to people. For each event check
one or more of the boxes to the right to indicate that: (a) it happened to you personally, (b) you witnessed it happen
to someone else, (c) you learned about it happening to someone close to you, (d) you’re not sure if it fits, or (e) it
doesn’t apply to you. Be sure to consider your entire life (growing up as well as adulthood) as you go through the
list of events.

Event

Happen
ed to
me

1. Natural disaster (for example, flood,
hurricane, tornado, earthquake)
2. Fire or explosion
3. Transportation accident (for example, car
accident, boat accident, train wreck, plane
crash)
4. Serious accident at work, home, or during
recreational activity
5. Exposure to toxic substance (for example,
dangerous chemicals, radiation)
6. Physical assault (for example, being attacked,
hit, slapped, kicked, beaten up)
7. Assault with at weapon (for example, being
shot, stabbed, threatened with a knife, gun,
bomb)
8. Sexual assault (rape, attempted rape, made to
perform any type of sexual act through force or
threat of harm)
9. Other unwanted or uncomfortable sexual
experience
10. Combat or exposure to a war-zone (in the
military or as a civilian)
11. Captivity (for example, being kidnapped,
abducted, held hostage, prisoner of war)
12. Life-threatening illness or injury
13. Severe human suffering
14. Sudden, violent death (for example,
homicide, suicide)
15. Sudden, unexpected death of someone close
to you
16. Serious injury, harm, or death you caused to
someone else
17. Any other very stressful event or experience
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Witne
ssed it

Learne
d about
it

Not
Sure

Doesn’t
apply

APPENDIX D: PTSD Checklist
Instructions: Below is a list of problems and complaints that people sometimes have in response to
stressful life experiences. Please read each one carefully, then circle one of the numbers to the right to
indicate how much you have been bothered by that problem in the past month.
The event you experienced was ________________________ on ______________.
(event)
(date)
Not at A little
Moder
Quite
all
bit
ately
a bit
1. Repeated, disturbing memories, thoughts, or
images of the stressful experience?
1
2
3
4
2. Repeated, disturbing dreams of the stressful
1
2
3
4
experience?
3. Suddenly acting or feeling as if the stressful
experience were happening again (as if you
1
2
3
4
were reliving it)?
4. Feeling very upset when something
1
2
3
4
reminded you of the stressful experience?
5. Having physical reactions (e.g., heart
pounding, trouble breathing, sweating) when
1
2
3
4
something reminded you of the stressful
experience?
6. Avoiding thinking about or talking about the
stressful experience or having feelings related
1
2
3
4
to it?
7. Avoiding activities or situations because
they reminded you of the stressful experience?
1
2
3
4
8. Trouble remembering important parts of the
1
2
3
4
stressful experience?
9. Loss of interest in activities that you used to
1
2
3
4
enjoy?
10. Feeling distant or cut off from other
1
2
3
4
people?
11. Feeling emotionally numb or unable to
1
2
3
4
have loving feelings for those close to you?
12. Feeling as if your future somehow will be
1
2
3
4
cut short?
13. Trouble falling or staying asleep?
1
2
3
4

Extrem
ely
5
5

5
5

5

5

5
5
5
5
5
5
5

14. Feeling irritable or having angry outbursts?

1

2

3

4

5

15. Having difficulty concentrating?

1

2

3

4

5

16. Being ―superalert‖ or watchful or on
guard?
17. Feeling jumpy or easily startled?

1

2

3

4

5

1

2

3

4

5
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Appendix E: Study Exclusion Form
Inclusion/Exclusion Summary Form
Research ID __________________
Needs “Yes” to one of the following:
YES

NO

Referred for PCT evaluation

YES

NO

Experienced significant trauma on LEC

Needs YES to all of the following:
YES

NO

Fits in a PTSD Severity group that is not closed to
recruitment (n = 70)

YES

NO

Veteran able to hear the computer administration.

YES

NO

Veteran speaks English

YES

NO

Veteran not currently reporting extreme distress
or significant suicidal or homicidal intent.

YES

NO

Veteran does not report a history or presence of
thought disorder
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Appendix F: Informed Consent Form
Department of Veterans Affairs VA Research Consent Form
Subject Name:
Date:
Title of Study: Psychometric Properties of the Computerized PTSD Scale –
Multimedia Version(CPS-M) Among Veterans
Principal Investigator: Sheila Rauch, PhD VAMC: VA Ann Arbor Healthcare System
PURPOSE OF RESEARCH STUDY:
The purpose of the study is to develop a computerized Posttraumatic Stress Disorder
assessment instrument. In order to conduct this investigation, we need to determine
the relationship between responses given to a computerized questionnaire, a face-toface interview, and other written questions. Your involvement will be for one session
that lasts about 120 to 180 minutes.
DESCRIPTION:
You have been found eligible to participate in the study based on the screening you
have completed. Up to 210 male/female veterans who are eligible will participate in
the study. Veterans will be assigned to groups based on the severity of their
symptoms. Seventy veterans in each of 3 symptom groups (e.g., mild /no symptoms,
moderate symptoms, and severe symptoms) will be enrolled. Veterans will be eligible
on a first come basis until the groups are filled (70 patients for each group).
During your participation in the study, you will sit in front of a computer for a
computerized assessment, fill out some paper-and-pencil forms, and complete a faceto-face interview. The order may vary; meaning, some people will complete the
computer segment first and others will complete the paper forms and interview first.
For the computer segment, you will answer questions using a computer mouse. This
software has sound files, so most questions will be read to you by the computer. This
usually takes about 30 minutes and the computer will let you know when it is finished.
The other segment involves completing paper-and-pencil forms and an interview.
This usually takes about 60-90 minutes. If any of the language in these forms is
confusing, please ask the research assistant for help. In each of these sections, you
will be asked about questions regarding past traumatic events and your reactions to
them. Some of the paper-and-pencil forms ask other questions about depression and
anxiety.
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RISKS:
Some people find it unpleasant to fill out the surveys or report upsetting memories.
However, this is a standard part of the assessment of traumatic events and PTSD.
Some questions may remind you of painful memories and cause some emotional
discomfort. There may be other risks that are unforeseeable at this time.
If you become distressed at any time during the interview or other assessments, you
may pause or discontinue participation in the study. Additionally, the study personnel
conducting the session may work with you to reduce negative reactions. If needed,
he/she will contact the principle investigator or other PCT clinicians in order to assist
with your care. Referral to psychiatry triage may be made as determined necessary.
The magnitude of harm if there is loss of confidentiality potentially includes social
damage to relationships with friends and peers, and secondly, damage to business
relationships that may decrease economic gains. In order to protect against breach of
confidentiality, all policies regarding training of research study staff and research data
management will be followed. All research data will be housed and secured at the VA
to ensure confidentiality and later destroyed by Dr. Rauch. Funding for this study is
provided through Eastern Michigan University. Your name and social security
number are required to be maintained and may be disclosed to research staff at
Eastern Michigan University for the purpose of reporting payment.
BENEFITS:
You are not likely to directly benefit by participating in this study. Your participation
will assist in the development of a new assessment tool for the improvement of
treatment for other people who have suffered from traumatic events.
ALTERNATE COURSES OF ACTION:
You do not have to participate in this study. You may drop out at any time without
penalty or loss of benefits entitled to you. If you consent to participate in this research
study, you may stop and leave at any time with no penalty to you. Your participation
is strictly voluntary. Your responses will not affect your eligibility for clinical care at
the VA Ann Arbor Healthcare System and cannot be used for service connection. The
results will not be entered into your medical record except in the instance of reported
danger to yourself or others (see below).
If participating in this study does bother you, you can stop and leave at any time
without any impact on your care at the VAAAHCS. You may also choose to take a
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break or discuss your feelings with study staff. If you are distressed, study staff may
ask that you meet briefly with a VA clinician face-to-face.
STATEMENT OF RESEARCH RESULTS:
Your identifying information (e.g., name) will be removed from the file in order to
protect your privacy. Your data will be assigned a research ID number. The research
data will be stored in a locked office and in a password protected computer at the
VAAAHCS. Data will be encrypted to provide additional protection. This
information will be destroyed after the all the data has been collected. To prevent any
potential negative consequences to you, any information gathered during the study
will not be included in your medical records unless you report risk of harm to self or
others (see below).
If the research in this study is published in journals or presented at conferences, it will
not be connected with your identifying information. As a participant, you are entitled
to a summary of the results, and if desired, this may be obtained from Dr. Sheila
Rauch at the VA PTSD Clinic (734-845-3545) or Dr. Dean Lauterbach at Eastern
Michigan University (734-487-0785).
We will let you know of any important discoveries made during this study which may
affect you, your condition, or your willingness to participate in this study. The study
includes surveys which may elicit information concerning suicidal and homicidal
intent, depression, or other major clinical findings. The research investigators will
notify your primary mental health provider and/or your treating psychologist if you
express these concerns. This contact will also be documented in your medical record.
SPECIAL CIRCUMSTANCES:
There will be no costs to you for any of the assessments done as part of this research
study. You may withdraw from the study at any time. There are no consequences for
discontinuing.
COMPENSATION:
After completion of the study session, you will receive a $10 gift card to a local
department store. However, completion of the individual study session is required to
receive the ten-dollar gift card.
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REQUEST FOR PATIENT AUTHORIZATION FOR ACCESS TO PROTECTED
HEALTH INFORMATION
1. By signing this document, you authorize the Veterans Health Administration (VHA)
to provide Sheila Rauch, Ph.D. and the research team permission to access your
Protected Health Information (medical chart data) for research purposes. This
information may include the following: Hospital records and reports; admission
history, and physical; X-ray films and reports; operative reports; laboratory reports;
treatment and test results; dental notes; immunizations; allergy reports; prescriptions;
consultations; clinic notes; and any other medical records needed by the research
team. **The investigators may view restricted information about you including: HIV
infection, Sickle Cell Anemia, drug and/ or alcohol abuse treatment.**
2. The research investigators will collect your Protected Health Information for the
following specific reasons: to determine your appointment history in either the PCT
or MHC clinics and to collect additional information about your mental health.
3. Your Protected Health Information, the research data and any identifying linkage
will be stored in a secure location. Your data will be assigned a research number and
will be encrypted to provide additional security. All data will be housed and stored
within a locked office and in a password protected computer on the VA network at
the VAAAHS.
4. You may refuse to sign this authorization and refuse to allow the disclosure of your
Protected Health Information. Your refusal will not affect your ability to receive
medical care or benefits at the VA Ann Arbor Healthcare System, but you will not be
eligible to participate in the study.
5. This authorization expires at the end of the study.
6. This authorization may be revoked at any time by sending a written request to:
Sheila Rauch, Ph.D., PTSD Clinical Team VA Ann Arbor Healthcare System 2215
Fuller Road (116c) Ann Arbor, MI 48105 If you revoke this authorization, Dr. Rauch
and the research team can continue to use information about you that has been
collected. No information will be collected after you revoke the authorization.
7. The Ann Arbor VAMC complies with the requirements of the Health Insurance
Portability and Accountability Act of 1996 and its privacy regulations and all other
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applicable laws that protect your privacy. We will protect your information according
to these laws. Despite these protections, there is a possibility that your information
could be used or disclosed in a way that it will no longer be protected.
8. Payments to research subjects are funded by a grant from Eastern Michigan
University. Eastern Michigan University research team staff will access your name
and social security number in order to process your payment.
RESEARCH SUBJECT’S RIGHTS:
____________________________________ has explained this research study and
answered all questions. The risks or discomforts and possible benefits of the study
have been described. Other choices of available treatment have been explained. Some
veterans are required to pay co-payments for medical care and services provided by
the VA. These co-payment requirements will continue to apply for VA care and
services that are not part of this research study.
Participation in this study is entirely voluntary. You may refuse to participate. Refusal
to participate will involve no penalty or loss of rights to which individuals are entitled.
Participants may withdraw from this study at any time without penalty or loss of VA
or other benefits. In the event that you sustain an injury or illness as a result
of your participation in this VA approved research study, all necessary medical
treatment (except in limited circumstances), will be provided in a VA medical facility.
You will be treated for the injury at no cost to you. However, no additional
compensation has been set aside. You have not waived any legal rights or released
the hospital or its agents from liability for negligence by signing this form.
In case there are medical problems or if you have questions, concerns or complaints
about the research study, you can contact member(s) of the research team: Sheila
Rauch, Ph.D. can be called at 734-845-3545 during the day and can be contacted after
hours by paging (734) 651-9379. You may contact the VA IRB coordinator (at 734845-3440) when staff members of the research study are not available to discuss
questions or concerns with someone other than research study staff. Research subjects
may learn more about research at the VA Ann Arbor Healthcare System at this
website: www1.va.gov/aavaresearch
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I am informed about my rights as a research subject, and I voluntarily consent to
participate in this study. I will receive a signed copy of this consent form.
x__________________________________ X________________________
Signature of Subject
Date
x___________________________________
Signature of Witness (A witness must observe the subject’s signature)
x___________________________________ X________________________
Witness (Print Name)
Date
x___________________________________
Signature of person obtaining consent (Study personnel must be approved by VA
IRB.)
x___________________________________ X________________________
Study Personnel (Print Name)
Date
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Appendix G: Demographic Questionnaire

125

APPENDIX H: Purdue PTSD Scale - Revised
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APPENDIX I: Trauma Related Dissociation Scale

TRDS
(Carlson & Waelde, 1999)

For each statement below, circle one of the choices to show how many times
each thing has happened to you in the past week.
NOT ONCE
AT
OR
3-6
7-10
ALL TWICE TIMES TIMES

MORE
THAN 10
TIMES

(IN THE PAST WEEK)

1. My body felt strange or unreal.
0
2. Things around me seemed strange or unreal.
0
3. I got reminded of something upsetting and
0
then spaced out for a while.
4. I had moments when I lost control and acted
0
like I was back in an upsetting time in my past.
5. I noticed that I couldn't remember the details
0
of something upsetting that happened to me.
6. Familiar places seemed strange or unreal.
0
7. I felt like I was outside myself, watching myself do things. 0
8. I heard something that I know really wasn't there.
0
9. I got upset about something and can't remember
0
what happened next.
10. I felt like I was in a movie - like nothing that
0
was happening was real.
11. I didn't feel pain when I was hurt and
0
should have felt something.
12. A memory came back to me that was so strong that
0
I lost track of what was going on around me.
13. I found myself staring into space and thinking of nothing. 0
14. I couldn't remember things that had happened
0
during the day even when I tried to.
15. I felt like I wasn't myself.
0
16. I felt like I was in a daze and couldn't make
0
sense of what was going on around me.
17. I saw something that seemed real, but was not.
0
18. I suddenly realized that I hadn't been paying
0
attention to what was going on around me.
19. I felt cut off from what was going on around me.
0
20. Parts of my body seemed distorted - like they
0
were bigger or smaller than usual.
21. I reacted to people or situations as if I were back
0
in an upsetting time in my past.
22. I got so focused on something going on in my mind that 0
I lost track of what was happening around me.
23. I noticed there were gaps in my memory for things
0
that happened to me that I should be able to remember.
24. I smelled something that I know really wasn't there.
0
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1-2
1-2
1-2

3-6
3-6
3-6

7-10
7-10
7-10

10+
10+
10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

1-2
1-2
1-2
1-2

3-6
3-6
3-6
3-6

7-10
7-10
7-10
7-10

10+
10+
10+
10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

1-2
1-2

3-6
3-6

7-10
7-10

10+
10+

1-2
1-2

3-6
3-6

7-10
7-10

10+
10+

1-2
1-2

3-6
3-6

7-10
7-10

10+
10+

1-2
1-2

3-6
3-6

7-10
7-10

10+
10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

1-2

3-6

7-10

10+

APPENDIX J: Beck Depression Inventory-II

BDI-II
This questionnaire consists of 21 groups of statements. After reading each group
of statements carefully, circle the number(0,1,2 or 3) next to the one statement in each
group which best describes the way you have been feeling the past week, including
today. If several statements within a group seem to apply equally well, circle each one.
Be sure to read all the statements in each group before making your choice.
1. 0 I do not feel sad.
1 I feel sad.
2 I am sad all the time and I can't snap out of it.
3 I am so sad or unhappy that I can't stand it.
2. 0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I have nothing to look forward to.
3 I feel I am a complete failure as a person.
3. 0 I do not feel like a failure.
1 I feel I have failed more the average person.
2 I As I look back on my life, all I can see is a lot of
failures.
3 I feel I am a complete failure as a person.
4. 0 I get as much satisfaction out of things as I used to.
1 I don't enjoy things the way I used to.
2 I don't get real satisfaction out of anything anymore
3 I am dissatisfied or bored with everything
5. 0 I don't feel particularly guilty.
1 I feel guilty a good part of the time.
2 I feel quite guilty most of the time.
3 I feel guilty all of the time.
6. 0 I don't feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7. 0 I don't feel disappointed in myself.
1 I am disappointed in myself.
2 I am disgusted with myself.
3 I hate myself.
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8. 0 I don't feel I am any worse than anybody else.
1 I am critical of myself for my weaknesses or mistakes.
2 I blame myself all the time for my faults.
3 I blame myself for everything bad that happens.
9. 0 I don't have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would not carry them out.
2 I would like to kill myself.
3 I would like to kill myself if I had the chance.
10. 0 I don't cry any more than usual.
1 I cry more now than I used to.
2 I cry all the time now.
3 I used to be able to cry, but now I can't cry even though I want to.
11. 0 I am no more irritated now than I ever am.
1 I get annoyed or irritated more easily than I used to.
2 I feel irritated all the time now.
3 I don't get irritated at all by the things that used to irritate me.
12. 0 I have not lost interest in other people.
1 I am less interested in other people than I used to be.
2 I have lost most of my interest in other people.
3 I have lost all of my interest in other people.
13. 0 I Make decisions about as well as I ever could.
1 I put off making decisions more than I used to.
2 I have greater difficulty in making decisions than before.
3 I can't make decisions at all anymore.
14. 0 I Don't feel I look any worse than I used to.
1 I am worried that I am looking old or unattractive.
2 I feel that there are permanent changes in my appearance
that make me look unattractive.
3 I believe that I look ugly.
15. 0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can't do any work at all.
16. 0 I can sleep as well as usual.
1 I don't sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
3 I wake up several hours earlier than I used to and cannot
get back to sleep.
129

17. 0 I don't get tired any more than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18. 0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19. 0 I haven't lost much weight, if any, lately.
1 I have lost more than 5 pounds.
2 I have lost more than 10 pounds.
3 I have lost more than 15 pounds.
I am purposely trying to lose weight by eating less.
YES_____________ NO______________
20. 0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and
pains; or upset stomach; or constipation.
2 I am very worried about physical problems and it's hard to
think of much else.
3 I am so worried about my physical problems that I cannot
think about anything else.
21 0 I have not noticed any recent change in my interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
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APPENDIX K: Clinician-Administered PTSD Scale

National Center for PTSD

CLINICIAN-ADMINISTERED PTSD SCALE FOR DSM-IV

(CAPS-DX)

Research # _________________________________
__________________________

Date:

Interviewer: _________________________________
for Acute Stress Disorder_

Study:

Session:

Posttest

3-Month Follow-up 6-Month Follow-up

Dudley D. Blake, Frank W. Weathers, Linda M. Nagy,
Danny G. Kaloupek, Dennis S. Charney, & Terence M. Keane
National Center for Posttraumatic Stress Disorder
Behavioral Science Division – Boston VA Medical Center
Neurosciences Division – West Haven VA Medical Center
Revised January 1997
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CBT

Criterion A. The person has been exposed to a traumatic event in which both of the following were present:
(1) the person experienced, witnessed, or was confronted with an event or events that involved actual or
threatened death or serious injury, or a threat to the physical integrity of self or others
(2) the person's response involved intense fear, helplessness, or horror. Note: In children, this may be
expressed instead by disorganized or agitated behavior

I'm going to be asking you about some difficult or stressful things that sometimes
happen to people. Some examples of this are being in some type of serious
accident; being in a fire, a hurricane, or an earthquake; being mugged or beaten
up or attacked with a weapon; or being forced to have sex when you didn't want
to. I'll start by asking you to look over a list of experiences like this and check
any that apply to you. Then, if any of them do apply to you, I'll ask you to briefly
describe what happened and how you felt at the time.
Some of these experiences may be hard to remember or may bring back
uncomfortable memories or feelings. People often find that talking about them
can be helpful, but it's up to you to decide how much you want to tell me. As we
go along, if you find yourself becoming upset, let me know and we can slow
down and talk about it. Also, if you have any questions or you don't understand
something, please let me know. Do you have any questions before we start?
ADMINISTER CHECKLIST, THEN REVIEW AND INQUIRE UP TO THREE
EVENTS. IF MORE THAN THREE EVENTS ENDORSED, DETERMINE
WHICH THREE EVENTS TO INQUIRE (E.G., FIRST, WORST, AND MOST
RECENT EVENTS; THREE WORST EVENTS; TRAUMA OF INTEREST PLUS
TWO OTHER WORST EVENTS, ETC.)
NO EVENTS ENDORSED ON CHECKLIST: (Has there ever been a time when
your life was in danger or you were seriously injured or harmed?)
IF NO: (What about a time when you were threatened with death or serious
injury, even if you weren't actually injured or harmed?)
IF NO: (What about witnessing something like this happen to someone
else or find out that it happened to someone close to you?)
IF NO: (What would you say are some of the most stressful experiences
you have had over your life?)
EVENT #1
What happened? (How old were
you? Who else was involved?
How many times did this happen?
Life threat? Serious injury?

How did you respond

Describe (e.g., event type, victim, perpetrator,
age, frequency):

A.(1)
Life threat?
[self____other___]
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NO

YES

emotionally? (Were you very
anxious or frightened? Horrified?
Helpless? How so? Were you
stunned or in shock so that you
didn't feel anything at all? What
was that like? What did other
people notice about your emotional
response? What about after the
event--how did you respond
emotionally?)

Serious injury?
[self____other___]

NO

YES

Threat to physical integrity? NO
[self____other___]

YES

A.(2)
Intense fear/help/horror?
after ____]
Criterion A met?
PROBABLE YES
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[during ____

NO

EVENT #2
What happened? (How old were
you? Who else was involved?
How many times did this happen?
Life threat? Serious injury?

How did you respond
emotionally? (Were you very
anxious or frightened? Horrified?
Helpless? How so? Were you
stunned or in shock so that you
didn't feel anything at all? What
was that like? What did other
people notice about your emotional
response? What about after the
event--how did you respond
emotionally?)

Describe (e.g., event type, victim, perpetrator,
age, frequency):

A.(1)
Life threat?
[self____other___]

NO

YES

NO

YES

Threat to physical integrity? NO
[self____other___]

YES

Serious injury?
[self____other___]

A.(2)
Intense fear/help/horror?
after ____]

[during ____

Criterion A met?
PROBABLE YES

EVENT #3
What happened? (How old were
you? Who else was involved?
How many times did this happen?
Life threat? Serious injury?

Describe (e.g., event type, victim, perpetrator,
age, frequency):

A.(1)
Life threat?
[self____other___]
How did you respond
emotionally? (Were you very
anxious or frightened? Horrified?
Helpless? How so? Were you
stunned or in shock so that you
didn't feel anything at all? What
was that like? What did other
people notice about your emotional
response? What about after the

NO

NO

YES

NO

YES

Threat to physical integrity? NO
[self____other___]

YES

Serious injury?
[self____other___]

A.(2)
Intense fear/help/horror?
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[during ____

event--how did you respond
emotionally?)

after ____]
Criterion A met?
PROBABLE YES

NO

For the rest of the interview, I want you to keep (EVENTS) in mind as I ask
you some questions about how they may have affected you.
I'm going to ask you about twenty-two questions altogether. Most of them
have two parts. First, I'll ask if you've ever had a particular problem, and if
so, about how often in the past month. Then I'll ask you how much distress
or discomfort that problem may have caused you.
CRITERION b. The traumatic event is persistently reexperienced in one (or more) of the following ways:

1. (B-1) recurrent and intrusive distressing recollection of the event, including
images, thoughts, or perceptions. Note: In young children, repetitive play
may occur in which themes or aspects of the trauma are expressed.
Frequency
Intensity
In the past month have you had
How much distress or discomfort
unwanted
did these memories cause you?
memories of (EVENT)? What were Were you able to put them out of
they like?
your mind and think about
(What did you remember?) [IF NOT
something else? (How hard did you
CLEAR:] (Did they ever occur while
have to try?) How much did they
you were awake, or only in dreams?) interfere with your life?
[EXCLUDE IF MEMORIES
OCCURRED ONLY DURING
0. None
DREAMS] How often?
1. Mild, minimal distress or disruption
of activities
0. Never
2. Moderate, distress clearly present
1. Once or twice
but still manageable, some
2. Once or twice per week
disruption of activities
3. Several times per week
3. Severe, considerable distress,
4. Daily or almost every day
difficulty dismissing memories,
marked disruption of activities
Description/Examples
4. Extreme, incapacitating distress,
cannot dismiss memories, unable
to continue activities
QV
(specify)_______________________
______
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Past
month
F ____
I ____
Sx: Y N

2. (B-2) recurrent distressing dreams of the event. Note: In children, there may
be frightening dreams without recognizable content.
Past
Frequency
Intensity
month
In the past month have you had
How much distress or discomfort
unpleasant dreams about
did these dreams cause you? Did
F ____
(EVENT)? Describe a typical
they ever wake you up? [IF YES:]
I ____
dream. (What happens in them?)
What happened when you woke up?
How often?
How long did it take you to get back to Sx: Y N
sleep?) [LISTEN FOR REPORT OF
0. Never
ANXIOUS AROUSAL, YELLING,
1. Once or twice
ACTING OUT THE NIGHTMARE]
2. Once or twice per week
(Did your dreams ever affect anyone
3. Several times per week
else? How so?)
4. Daily or almost every day
Description/Examples

0. None
1. Mild, minimal distress, may not
have awoken
2. Moderate, awoke in distress but
readily returned to sleep
3. Severe, considerable distress,
difficulty returning to sleep
4. Extreme, incapacitating distress,
did not return to sleep
QV
(specify)_______________________
______

3. (B-3) acting or feeling as if the traumatic event were recurring (includes a
sense of reliving the experience, illusions, hallucinations, and dissociative
flashback episodes, including those that occur on awakening or when
intoxicated).
Note: In young children, trauma-specific reenactment may occur.
Frequency
Intensity
In the past month have you
How much did it seem as if
suddenly acted or felt as if
(EVENT) were happening again?
(EVENT) were happening again
(Were you confused about where you
(Have you ever had flashbacks about actually were or what you were doing
[EVENT]?) [IF NOT CLEAR:] (Did
at the time?) How long did it last?
this ever occur while you were
What did you do while this was
awake, or only in dreams?)
happening? (Did other people notice
[EXCLUDE IF OCCURRED ONLY
your behavior? What did they say?)
DURING DREAMS] Tell me more
about that. How often?
0. None
1. Mild, somewhat more realistic than
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Past
month
F ____
I ____
Sx: Y N

0.
1.
2.
3.
4.

Never
Once or twice
Once or twice per week
Several times per week
Daily or almost every day

Description/Examples

just thinking about event
2. Moderate, definite but transient
dissociative quality, still very aware
of surroundings, daydreaming
quality
3. Severe, strongly dissociative
(reports images, sounds, or
smells) but retained some
awareness of surroundings
4. Extreme, complete dissociation
(flashback), no awareness of
surroundings, may be
unresponsive, possible amnesia
for the episode (blackout)
QV
(specify)_______________________
_____

4. (B-4) intense psychological distress at exposure to internal or external cues
that symbolize or resemble an aspect of the traumatic event
Frequency
Intensity
In the past month have you gotten How much distress or discomfort
emotionally upset when something did (REMINDERS) cause you? How
reminded you of (EVENT)? (Has
long did it last? How much did it
anything ever triggered bad feelings
interfere with your life?
related to [EVENT]?) What kinds of
reminders made you upset? How
0. None
often?
1. Mild, minimal distress or disruption
of activities
0. Never
2. Moderate, distress clearly present
1. Once or twice
but still manageable, some
2. Once or twice per week
disruption of activities
3. Several times per week
3. Severe, considerable distress,
4. Daily or almost every day
difficulty dismissing memories,
marked disruption of activities
Description/Examples
4. Extreme, incapacitating distress,
unable to continue activities
QV
(specify)_______________________
______
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Past
month
F ____
I ____

Sx: Y N

5. (B-5) physiological reactivity on exposure to internal or external cues that
symbolize or resemble an aspect of the traumatic event
Frequency
In the past month have you had
any physical reactions when
something reminded you of
(EVENT)? (Did your body ever react
in some way when something
reminded you of {EVENT}? Can you
give me some examples? (Did your
heart race or your breathing change?
What about sweating or feeling really
tense or shaky?) What kinds of
reminders triggered these
reactions? How often?
0.
1.
2.
3.
4.

Never
Once or twice
Once or twice per week
Several times per week
Daily or almost every day

Intensity
How strong were (PHYSICAL
REACTIONS)? How long did they
last? (Did they last even after you
were out of the situation?)

Past
month
F ____
I ____
Sx: Y N

0. No physical reactivity
1. Mild, minimal reactivity
2. Moderate, physical reactivity
clearly present, may be sustained
if exposure continues
3. Severe, marked physical reactivity,
sustained throughout exposure
4. Extreme, dramatic physical
reactivity, sustained arousal even
after exposure has ended
QV
(specify)_______________________
______

Description/Examples

Criterion C. Persistent avoidance of stimuli associated with the trauma and
numbing of general responsiveness (not present before the trauma),
as indicated by three (or more) of the following:
6. (C-1) efforts to avoid thoughts, feelings or conversations associated with
trauma
Frequency
Intensity
How much effort did you make to avoid
In the past month have you
(THOUGHTS/FEELINGS/CONVERSATION
tried to avoid thoughts or
feelings about (EVENT)? (What S)?
kinds of thoughts or feelings did
(What kinds of things did you do? What
you try to avoid?) What about
about drinking or using medication or
trying to avoid talking with
street drugs?) [CONSIDER ALL
other people about it? (Why is ATTEMPTS AT AVOIDANCE,
that?) How often?
INCLUDING DISTRACTION,
0. Never

SUPPRESSION, AND USE OF
ALCOHOL/DRUGS] How much did that
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Past
month
F ____
I ____
Sx: Y N

1.
2.
3.
4.

Once or twice
Once or twice per week
Several times per week
Daily or almost every day

Description/Examples

interfere with your life?
0. None
1. Mild, minimal effort, little or no
disruption of activities
2. Moderate, some effort, avoidance
definitely present, some disruption of
activities
3. Severe, considerable effort, marked
avoidance, marked disruption of
activities, or involvement in certain
activities as avoidance strategy
4. Extreme, drastic attempts at
avoidance, unable to continue
activities, or excessive involvement in
certain activities as avoidance strategy.

QV
(specify)__________________________
___
7. (C-2) efforts to avoid activities, places, or people that arouse recollections of
the trauma
Frequency
Intensity
In the past month have you
How much effort did you make to avoid
tried to avoid certain activities, (ACTIVITIES/PLACES/PEOPLE)? (What
places, or people that
did you do instead?) How much did that
reminded you of (EVENT)?
interfere with your life?
(What kinds of things did you
avoid? Why is that?) How
0. None
often?
1. Mild, minimal effort, little or no
disruption of activities
0. Never
2. Moderate, some effort, avoidance
1. Once or twice
definitely present, some disruption of
2. Once or twice per week
activities
3. Several times per week
3. Severe, considerable effort, marked
4. Daily or almost every day
avoidance, marked disruption of
activities, or involvement in certain
Description/Examples
activities as avoidance strategy
4. Extreme, drastic attempts at
avoidance, unable to continue
activities, or excessive involvement in
certain activities as avoidance strategy
QV
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Past
month
F ____
I ____
Sx: Y N

(specify)_______________________________
_

8. (C-3) inability to recall an important aspect of the trauma
Frequency
Intensity
In the past month have you had difficulty
How much effort difficulty
remembering some important parts of
did you have recalling
(EVENT)? Tell me more about that. (Do you important parts of
feel you should be able to remember these
(EVENT) (Were you able to
things? Why do you think you can’t?) How
recall more if you tried?)
much of the important parts of (EVENT)
have you had difficulty remembering? (What 0. None
parts do you still remember?)
1. Mild, minimal difficulty
2. Moderate, some
0. None, clear memory
difficulty, could recall
1. Few aspects not remembered (less than
with effort
10%)
3. Severe, considerable
2. Some aspects not remembered (approx. 20difficulty, even with effort
30%)
4. Extreme, completely
3. Many aspects not remembered (approx. 50unable to recall
60%)
important aspects of
4. Most or all aspects not remembered (more
event
than 80%)
QV
Description/Examples
(specify)__________________
_
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Past
month
F ____
I ____
Sx: Y N

9. (C-4) markedly diminished interest or participation in significant activities
Frequency
Intensity
In the past month have you been less interested How strong was your loss of
in activities that you used to enjoy? (What
interest? (Would you enjoy
kinds of things have you lost interest in? Are [ACTIVITIES] once you got
there some things you don’t do at all
started?)
anymore? Why is that?) [EXCLUDE IF NO
OPPORTUNITY, IF PHYSICALLY
0. No loss of interest
UNABLE, OR IF DEVELOPMENTALLY
1. Mild, slight loss of interest,
APPROPRIATE CHANGE IN
probably would enjoy after
PREFERRED ACTIVITIES] How many
starting activities
activities have you been less interested in?
2. Moderate, definite loss of
(What kinds of things do you still enjoy
interest, but still has some
doing?) When did you first start to feel that
enjoyment of activities
way? (After the [EVENT]?)
3. Severe, marked loss of
interest in activities
4. Extreme, complete loss of
0. None
interest, no longer
1. Few activities (less than 10%)
participates in any activities
2. Some activities (approx. 20-30%)
3. Many activities (approx. 50-60%)
4. Most or all activities (more than 80%)

QV

Description/Examples

(specify)______________________

Past
month
F ____
I ____
Sx: Y N

__

Trauma-related?
1 definite 2 probable
unlikely
Current _____
_____

3

Lifetime

10. (C-5) feeling of detachment or estrangement from others
Frequency
Intensity
In the past month have you felt
How strong were your feelings of being
distant or cut off from other people? distant or cut off from others? (Whom do
What was that like? How much of
you feel closest to? How many people do
the time? When did you first start
you feel comfortable talking with about
to feel that way? (After the
personal things?)
[EVENT]?)
0. No feelings of detachment or
estrangement
0. None
1. Mild, may feel “out of synch” with others
1. Very little of the time (less
2. Moderate, feelings of detachment
than 10%)
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Past
month
F ____
I ____
Sx: Y N

2. Some of the time (approx.
20-30%)
3. Much of the time (approx.
50-60%)
4. Most or all of the time (more
than 80%)
Description/Examples

clearly present, but still feels some
interpersonal connection
3. Severe, marked feelings of detachment
or estrangement from most people, may
feel close to only one or two people
4. Extreme, feels completely detached or
estranged from others, not close with
anyone
QV (specify)____________________________

Trauma-related?
1 definite 2 probable
Current _____
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3 unlikely

Lifetime _____

11. (C-6) restricted range of affect (e.g., unable to have loving feelings)
Frequency
Intensity
In the past month have there been
How much trouble did you have
times when you felt emotionally numb experiencing (EMOTIONS)? (What
or had trouble experiencing feelings
kinds of feelings are you still able to
like love or happiness? What was that experience?) [INCLUDE
like? (What feelings did you have
OBSERVATIONS OF RANGE OF
trouble experiencing?) How much of AFFECT DURING INTERVEW]
the time? When did you first start
having trouble experiencing
0. No reduction of emotional experience
(EMOTIONS)? (After the
1. Mild, slight reduction of emotional
[EVENT]?)
experience
2. Moderate, definite reduction of
emotional experience, but still able to
0. None of the time
experience most emotions
1. Very little of the time (less than
3.
Severe, marked reduction of
10%)
experience of at least two primary
2. Some of the time (approx. 20emotions (e.g., love, happiness)
30%)
4. Extreme, completely lacking
3. Much of the time (approx. 50emotional experience
60%)
4. Most or all of the time (more
than 80%)

QV

Description/Examples

(specify)_____________________________

Trauma-related?
1 definite 2 probable
Current _____

Past
month
F ____
I ____
Sx: Y N

3 unlikely

Lifetime _____

12. (C-7) sense of a foreshortened future (e.g. does not expect to have a career,
marriage, children, or a normal life
Past
Frequency
Intensity
month
In the past month have there been times How strong was this feeling that
when you felt there is no need to plan
your future will be cut short? (How
F ____
for the future, that somehow your future long do you think you will live? How
I ____
will be cut short? Why is that? [RULE convinced are you that you will die
OUT REALISTIC RISKS SUCH AS
prematurely?)
Sx: Y N
LIFE-THREATENING MEDICAL
CONDITONS] How much of the time? 0. No sense of a foreshortened future
When did you first start to gel that way? 1. Mild, slight sense of a
(After the [EVENT]?)
foreshortened future
2. Moderate sense of a foreshortened
future but no specific prediction
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0. None of the time
1. Very little of the time (less than
10%)
2. Some of the time (approx. 2030%)
3. Much of the time (approx. 5060%)
4. Most or all of the time (more than
80%)

about longevity
3. Severe, marked sense of a
foreshortened future, may make
specific prediction about longevity
4. Extreme, overwhelming sense of a
foreshortened future, completely
convinced of premature death

Description/Examples

(specify)____________________________

QV

_

Trauma-related?
1 definite 2 probable
Current _____

3 unlikely

Lifetime _____

Criterion D. Persistent symptoms of increased arousal (not present before the
trauma), as indicated by two (or more) of the following:
13. (D-1) difficulty falling or staying asleep
Frequency
Intensity
In the past month have you had any How much of a problem did you have
problems falling or staying asleep? with your sleep? (How long did it take for
How often? When did you first
you to fall asleep? How often did you wake
start having problems sleeping?
up in the night? Did you often wake up
(After the [EVENT]?)
earlier than you wanted to? How many
total hours did you sleep each night?
0.
1.
2.
3.
4.

Never
Once or twice
Once or twice per week
Several times per week
Daily or almost every day

Sleep onset problems?
N

Y

Mid-sleep awakening?
N

Y

Early a.m. awakening?
N

Y

0. No sleep problems
1. Mild, slightly longer latency, or minimal
difficulty staying asleep (up to 30
minutes loss of sleep)
2. Moderate, definite sleep disturbance,
clearly longer latency, or clear difficulty
staying asleep (30-90 minutes loss of
sleep)
3. Severe, much longer latency, or marked
difficulty staying asleep (90 min to 3 hrs
loss of sleep)
4. Extreme, very long latency, or profound
difficulty staying asleep (> 3 hrs loss of
sleep)
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Past
month
F ____
I ____
Sx: Y N

Total # hrs sleep/night
______

QV

Desired # hrs sleep/night
______

(specify)______________________________

Trauma-related?
1 definite 2 probable
Current _____

3 unlikely

Lifetime _____

14. (D-2) irritability or outbursts of anger
Frequency
Intensity
In the past month have there
How strong was your anger? (How did you
been times when you felt
show it?) [IF REPORTS SUPPRESSION:]
especially irritable or showed
(How hard was it for you to keep from showing
strong feelings of anger? Can
your anger?) How long did it take you to
you give me some examples?
calm down? Did your anger cause you any
How often? When did you
problems?
first start feeling that way?
(After the [EVENT]?)
0. No irritability or anger
1. Mild, minimal irritability, may raise voice
when angry
0. Never
2.
Moderate, definite irritability or attempts to
1. Once or twice
suppress anger, but can recover quickly
2. Once or twice per week
3.
Severe, marked irritability or marked
3. Several times per week
attempts to suppress anger, may become
4. Daily or almost every
verbally or physically aggressive when
day
angry
4. Extreme, pervasive anger or drastic
Description/Examples
attempts to suppress anger, may have
episodes of physical violence

Past
month
F ____
I ____
Sx: Y N

QV (specify)______________________________

Trauma-related?
1 definite 2 probable
Current _____
15. (D-3) difficulty concentrating
Frequency
In the past month have you found it
difficult to concentrate on what you
were doing or on things going on
around you? What was that like?

3 unlikely

Lifetime _____

Intensity
How difficult was it for you to
concentrate? [INCLUDE
OBSERVATIONS OF CONCENTRATION
AND ATTENTION IN INTERVIEW]? How
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Past
month
F ____
I ____

How much of the time? When did
you first start having trouble
concentrating? (After the
[EVENT]?)
0. None of the time
1. Very little of the time (less
than 10%)
2. Some of the time (approx. 2030%)
3. Much of the time (approx. 5060%)
4. Most or all of the time (more
than 80%)
Description/Examples

much did that interfere with your life?

Sx: Y N

0. No difficulty with concentration
1. Mild, only slight effort needed to
concentrate, little or no disruption of
activities
2. Moderate, definite loss of
concentration but could concentrate
with effort, some disruption of
activities
3. Severe, marked loss of concentration
even with effort, marked disruption of
activities
4. Extreme, complete inability to
concentrate, unable to engage in
activities
QV
(specify)______________________________
__

Trauma-related?
1 definite 2 probable
Current _____
16. (D-4) hypervigilance
Frequency
In the past month have you been
especially alert or watchful, even
when there was no real need to be?
(Have you felt as if you were
constantly on guard?) What is
that? How much of the time?
When did you first start acting that
way? (After the [EVENT]?)
0. None of the time
1. Very little of the time (less
than 10%)
2. Some of the time (approx.
20-30%)
3. Much of the time (approx.

3 unlikely

Lifetime _____

Intensity
How hard did you try to be watchful of
things going on around you [INCLUDE
OBSERVATIONS OF HYPERVIGILANCE
IN INTERVIEW]? Did your
(HYPERVIGILANCE) cause you any
problems?
0. No hypervigilance
1. Mild, minimal hypervigilance, slight
heightening of awareness
2. Moderate, hypervigilance clearly
present, watchful in public (e.g., chooses
safe place to sit in a restaurant or movie
theater)
3. Severe, marked hypervigilance, very
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Past
month
F ____
I ____
Sx: Y N

50-60%)
4. Most or all of the time (more
than 80%)
Description/Examples

alert, scans environment for danger,
exaggerated concern for safety of
self/family/home
4. Extreme, excessive hypervigilance,
efforts to ensure safety consume
significant time and energy and may
involve extensive safety/checking
behaviors, marked watchfulness during
interview
QV
(specify)________________________________

Trauma-related?
1 definite 2 probable
Current _____
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3 unlikely

Lifetime _____

17. (D-5) exaggerated startle response
Frequency
Intensity
In the past month have you had any
How strong were these startle
strong startle reactions? When did that reactions? (How strong were they
happen? (What kinds of things made
compared to how most people would
you startle?) How often? When did
respond? How long did they last?
you first have these reactions? (After
the [EVENT]?)
0. No startle reaction
1. Mild, minimal startle reaction
2. Moderate, definite startle reaction,
0. Never
feels “jumpy”
1. Once or twice
3.
Severe, marked startle reaction,
2. Once or twice per week
sustained arousal following initial
3. Several times per week
reaction
4. Daily or almost every day
4. Extreme, excessive startle reaction,
overt coping behavior j(e.g., combat
Description/Examples
veteran who “hits the dirt”)

Past
month
F ____
I ____
Sx: Y N

QV
(specify)____________________________
___

Trauma-related?
1 definite 2 probable
Current _____

3 unlikely

Lifetime _____

CRITERION E. Duration of the disturbance (symptoms in Criteria B, C, and D) is
more than 1 month.
18. onset of symptoms
[IF NOT ALREADY CLEAR:] When did you first
__________ total # months delay
start having (PTSD SYMPTOMS) you've told me in onset
about? (How long after the trauma did they start?
More than six months?)
With delayed onset ( 6 months)?
NO
19. duration of symptoms
How long have these (PTSD
SYMPTOMS) lasted altogether?
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YES

Duration more than 1 month?

NO

Total # months duration

YES

Acute (< 3 months) or chronic ( 3 months)?

________

Duration > 6 months?

acute
chronic
NO

YES

CRITERION F. The disturbance causes clinically significant distress or
impairment in social, occupational, or other important areas of
functioning.
20. subjective distress
Overall, in the past month how much 0. None
1. Mild, minimal distress
have you been bothered by these
2. Moderate distress clearly present but
still manageable
(PTSD SYMPTOMS) you’ve told me 3. Severe, considerable distress
4. Extreme, incapacitating distress
about? [CONSIDER DISTRESS

Past
month
________

REPORTED ON EARLIER
ITEMS]

21. impairment in social functioning
In the past month have these 0. No adverse impact
1. Mild impact, minimal impairment in social
(PTSD SYMPTOMS) affected
functioning
2. Moderate impact, definite impairment, but
your relationships with other
many aspects of social functioning still intact
3. Severe impact, marked impairment, few
people? [CONSIDER
aspects of social functioning still intact
4. Extreme, impact, little or no social
IMPAIRMENT IN SOCIAL
functioning
FUNCTIONING
REPORTED ON EARLIER
ITEMS]

22. impairment in occupational or other important area of functioning
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Past
month
________

0. No adverse impact
1. Mild impact, minimal
impairment in
IF YES: Have these (PTSD SYMPTOMS) affected
occupational/other
your work or your ability to work in the past
important functioning
month? How so? [CONSIDER REPORTED
2. Moderate impact, definite
WORK HISTORY, INCLUDING NUMBER AND
impairment, but many
DURATION OF JBOS, AS WELL AS THE QUALITY
aspects of
OF WORK RELATIONSHIPS. IF PREMORBID
occupational/other
FUNCTIONING IS UNCLEAR, INQUIRE ABOUT
important functioning still
WORK EXPERIENCES BEFORE THE TRAUMA.
intact
FOR CHILD/ADOLESCENT TRAUMAS, ASSESS
3. Severe impact, marked
PRE-TRAUMA SCHOOL PERFORMANCE AND
impairment, few aspects
POSSIBLE PRESENCE OF BEHAVIOR
of occupational/other
PROBLEMS]
important functioning still
intact
IF NO: In the past month, have these (PTSD
4. Extreme impact, little or
SYMPTOMS) affected any other important part of
no occupational/other
your life? [AS APPROPRIATE, SUGGEST
important functioning
EXAMPLES SUCH AS PARENTING, HOUSEWORK,
SCHOOLWORK, VOLUNTEER WORK, ETC.] How
so?
[IF NOT ALREADY CLEAR] Are you working now?

GLOBAL RATINGS

23. global validity
ESTIMATE THE OVERALL VALIDITY
OF RESPONSES. CONSIDER SUCH
ISSUES AS COMPLAINCE WITH THE
INTERVIEW, PATIENT STATUS (E.G.,
PROBLEMS WITH CONCENTRATION,
COMPREHENSION OF ITEMS,
DISSOCIATION), AND EVIDENCE OF
EFFORTS TO EXAGGERATE OR
MINIMIZE SYMPTOMS

0. Excellent, no reason to suspect invalid
responses
1. Good, factors present that may
adversely affect validity
2. Fair, factors present that definitely
reduce validity
3. Poor, substantially reduced validity
4. Invalid responses, severely impaired
mental status or possible deliberate
“faking bad” or “faking good”

24. global severity
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0. No clinically significant symptoms, no
distress and no functional impairment
OF PTSD SYMPTOMS. CONSIDER
1. Mild, minimal distress or functional
impairment
DEGREE OF SUBJECTIVE DISTRESS, 2. Moderate, definite distress or functional
impairment but functions satisfactorily
DEGREE OF FUNCITONAL
with effort
3. Severe, considerable distress or
IMPARIMENT, OBSERVATIONS OF
functional impairment, limited functioning
even with effort
BEHAVIORS IN INTERVIEW, AND
4. Extreme, marked distress or marked
impairment in two or more major areas
JUDGMENT REGARDING REPORTING
of functioning
ESTIMATE THE OVERALL SEVERITY

STYLE.

25. global improvement
RATE TOTAL OVERALL
IMPROVEMENT PRESENT SINCE THE
INITIAL RATING. IF NO EARLIER
RATING, ASK HOW THE SYMPTOMS
ENDORESED HAVE CHANGED OVER
THE PAST 6 MONTHS. RATE THE
DEGREE OF CHANGE, WHETHER OR
NOT, IN YOUR JUDGEMENT, IT IS DUE
TO TREATMENT

0.
1.
2.
3.
4.
5.

Asymptomatic
Considerable improvement
Moderate improvement
Slight improvement
No improvement
Insufficient information

Associated Features
26. guilt over acts of commission or omission
Frequency
Intensity
In the past month have you felt
How strong were these feelings of
guilty about anything you did or
guilt? How much distress or
didn’t do during (EVENT)? Tell me discomfort did they cause?
more about that. (What do you feel
guilty about?) How much of the
0. No feelings of guilt
time?
1. Mild, slight feelings of guilt
2. Moderate, guilt feelings definitely
0. None of the time
present, some distress but still
1. Very little of the time (less than
manageable
10%)
3. Severe, marked feelings of guilt,
2. Some of the time (approx. 20considerable distress
30%)
4. Extreme, pervasive feelings of guilt,
3. Much of the time (approx. 50self-condemnation regarding
60%)
behavior, incapacitating distress
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Past
month
F ____
I ____

4. Most or all of the time (more than
80%)
Description/Examples

QV
(specify)________________________
_____

27. survivor guilt [APPLICABLE ONLY IF MULTIPLE VICTIMS]
Frequency
Intensity
In the past month have you felt
How strong were these feelings of
guilty about SURVIVING (EVENT)
guilt? How much distress or
WHEN OTHERS DID NOT? Tell me discomfort did they cause?
more about that. (What do you feel
guilty about?) How much of the
0. No feelings of guilt
time?
1. Mild, slight feelings of guilt
2. Moderate, guilt feelings definitely
0. None of the time
present, some distress but still
1. Very little of the time (less than
manageable
10%)
3. Severe, marked feelings of guilt,
2. Some of the time (approx. 20considerable distress
30%)
4. Extreme, pervasive feelings of guilt,
3. Much of the time (approx. 50self-condemnation regarding
60%)
behavior, incapacitating distress
4. Most or all of the time (more than
80%)
QV
(specify)________________________
Description/Examples
______
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Past
month
F ____
I ____

28. a reduction in awareness of his or her surrounding (e.g., “being in a daze)
Frequency
Intensity
In the past month have there been times How strong was this feeling of being
when you felt out of touch with things
out of touch or in a daze? (Were you
going on around you, like you were in a confused about where you actually were
daze? What was that like?
or what you were doing at the time?)?
[DISTINGUISH FROM
How long did it last? What did you do
FLASHBACK EPISODERS] How
while this was happening? (Did other
often? [IF NOT CLEAR:] (Was it
people notice your behavior? What did
due to an illness or the effects of
they say?)
drugs or alcohol?) When did you first
start feeling that way? (After the
0. No reduction in awareness
[EVENT]?)
1. Mild, slight reduction in awareness
2. Moderate, definite but transient
reduction in awareness, may report
0. Never
feeling “spacey”
1. Once or twice
3. Severe, marked reduction in
2. Once or twice per week
awareness, may persist for several
3. Several times per week
hours
4. Daily or almost every day
4. Extreme, complete reduction in
awareness of surroundings, may be
Description/Examples
unresponsive, possible amnesia for
the episode (blackout)

Past
month
F ____
I ____

QV
(specify)____________________________
__

Trauma-related?
1 definite 2 probable
Current _____

29. derealization
Frequency
In the past month have there been times
when things going on around you seemed
unreal or very strange or unfamiliar? [IF
NO:] (What about times when people you
knew suddenly seemed unfamiliar?) What
was that like? How often? [IF NOT
CLEAR:] (Was it due to an illness or the
153

3 unlikely

Lifetime _____

Intensity
How strong was
(DEREALIZATION)? How long did
it last? What did you do while
this was happening? (Did other
people notice your behavior? What
did they say?)

Past
month
F ____
I ____

0. No derealization
1. Mild, slight derealization
2. Moderate, definite but transient
derealization
3. Severe, considerable
derealization, marked confusion
about what is real, may persist
for several hours
4. Extreme, profound derealization,
dramatic loss of sense of reality
or familiarity

effects of drugs or alcohol?) When did
you first start feeling that way? (After the
[EVENT]?)
0.
1.
2.
3.
4.

Never
Once or twice
Once or twice per week
Several times per week
Daily or almost every day
Description/Examples

QV
(specify)_________________________
__

Trauma-related?
1 definite 2 probable
unlikely
Current _____
30. depersonalization
Frequency
In the past month have there been times
when you felt as if you were outside of
your body, watching yourself as if you
were another person? [IF NO:] (What
about times when your body felt
strange or unfamiliar to you, as if it
had changed in some way?) What was
that like? How often? [IF NOT
CLEAR:] (Was it due to an illness or
the effects of drugs or alcohol?) When
did you first start feeling that way?
(After the [EVENT]?)
0.
1.
2.
3.
4.

Never
Once or twice
Once or twice per week
Several times per week
Daily or almost every day

3

Lifetime _____

Intensity
How strong was
(DEPERSONALIZATION)? How long
did it last? What did you do while
this was happening? (Did other
people notice your behavior? What
did they say?)
0. No depersonalization
1. Mild, slight depersonalization
2. Moderate, definite but transient
depersonalization
3. Severe, considerable
depersonalization, marked of
detachment from self, may persist
for several hours
4. Extreme, profound
depersonalization, dramatic loss of
sense of detachment from self
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Past
month
F ____
I ____

Description/Examples

QV
(specify)___________________________
__

Trauma-related?
1 definite 2 probable
Current _____
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3 unlikely

Lifetime _____

APPENDIX L: Debriefing Form
Debriefing Form
The purpose of this research was to compare how well different formats of PTSD instruments
agree with one another for diagnostic purposes. You were selected for the research because you
indicated experiencing some level of stress in response to an event in your life. People who were
asked to continue their participation varied widely in the nature of their responses – some
acknowledged severe symptoms while others were almost asymptomatic.
Please keep in mind that all information collected during this research project is confidential.
Your identifying information (e.g.-name) will be removed from the file in order to protect your
privacy. Your data will be assigned a research ID number based on how many participants have
already completed the study. The research data will be stored in a locked office and in a
password protected computer at the VAAAHCS. Data will be encrypted to provide additional
protection. To prevent any potential negative consequences to you, and information gathered
during the study will not be included in your medical records unless you report risk of harm to
self or others. Data will be retained for 7 years after the last publication from the data set.
Patient identifiers connected to research ID numbers will be included in a file also secured at the
VA that is stored in a locked cabinet separate from the rest of the study data and destroyed at the
same interval as the study data.
Sometimes discussing stressful events can be distressing and cause a person to remember
troubling events. Persons often become tearful or upset when responding to questions like those
that you answered today. If you are feeling upset, please tell the interviewer. There is no rush to
leave, if you need a few minutes to regain your composure, please stay until you feel better.
If you find that you continue to have difficulty managing your emotions after you leave this
session or believe you may be a danger to yourself or others, professional help is available to you.
Veterans should contact their primary provider at the VA. Veterans can also access triage
services at the Mental Health Clinic. The phone number is 734-213-6998. If you need help
when this center is closed, please contact 911 emergency services for mental health assistance.
Above all, please feel free to contact Dr. Sheila Rauch at (734) 769-7100 x6040 or Dr. Dean
Lauterbach at (734) 487-0785 if you are having any difficulties as a result of this study.
While we do not expect many individuals to develop symptoms that warrant further care, you
should be aware that there are many treatment options available to you and that it is not unusual
to feel down for a while after discussing a traumatic event.
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